Issam Raad, M.D., FACP, FIDSA, FSHEA

Peer-Reviewed Articles

1. Haddad A, Wilson Dib R, Chaftari AM, Jiang Y, Moussa M, Dagher H, Philip A, Hachem R, Raad I. Risk factors for catheter-related bloodstream infections in a high-risk cancer patient population. Infect Control Hosp Epidemiol:1-4, 2025. e-Pub 2025. PMID: 40415573.
2. Wehbe S, Chaftari AM, Hachem R, Dagher H, Haddad A, Philip A, Jiang Y, Zakhour R, Bakht P, Shrestha J, Lamie P, Sherchan R, Makhoul J, Chaftari P, Raad II. Prognostic Value of Serum and Bronchoalveolar Lavage Fluid Galactomannan Levels in Invasive Aspergillosis: An 8-Year Experience at a Tertiary Cancer Center. J Fungi (Basel) 11(5), 2025. e-Pub 2025. PMID: 40422689.
3. Sasaki K, Garcia-Manero G, Nigo M, Jabbour E, Ravandi F, Wierda WG, Jain N, Takahashi K, Montalban-Bravo G, Daver NG, Thompson PA, Pemmaraju N, Kontoyiannis DP, Sato J, Karimaghaei S, Soltysiak KA, Raad II, Kantarjian HM, Carter BW. Artificial Intelligence Assessment of Chest Radiographs for COVID-19. Clin Lymphoma Myeloma Leuk 25(5):319-327, 2025. e-Pub 2025. PMID: 39710565.
4. Truong YL, Rosenblatt J, Gerges B, Jiang Y, Raad I. Comparative In Vitro Antimicrobial Activity of a Silver and Minocycline-Rifampin-Chlorhexidine Coated Needle-Free Connector. J Hosp Infect, 2025. e-Pub 2025. PMID: 40288584.
5. Gerges BZ, Rosenblatt J, Truong YL, Jiang Y, Raad II. The Antifungal Activity of a Polygalacturonic and Caprylic Acid Ointment in an In Vitro, Three-Dimensional Wound Biofilm Model. J Fungi (Basel) 11(3), 2025. e-Pub 2025. PMID: 40137216.
6. Dagher H, Chaftari AM, Haddad A, Jiang Y, Shrestha J, Sherchan R, Lamie P, Makhoul J, Chaftari P, Hachem R, Raad I. Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients. J Fungi (Basel) 11(2), 2025. e-Pub 2025. PMID: 39997454.
7. Hachem RY, Dagher H, Chaftari AM, Jiang Y, Haddad A, Wehbe S, Shrestha J, Sherchan R, Lamie P, Makhoul J, Chaftari P, Raad II. Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by Aspergillus terreus After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer Center. J Fungi (Basel) 11(2), 2025. e-Pub 2025. PMID: 39997413.
8. Truong YL, Rosenblatt J, Gerges B, Jiang Y, Raad I. Eradication of Candida auris biofilm in vitro by a polygalacturonic and caprylic acid wound ointment. J Mycol Med 34(4):101519, 2024. e-Pub 2024. PMID: 39549521.
9. Dagher H, Chaftari AM, Hachem R, Jiang Y, Philip A, Mulanovich P, Haddad A, Lamie P, Wilson Dib R, John TM, Dailey Garnes NJM, Ali S, Chaftari P, Raad II. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel) 16(20), 2024. e-Pub 2024. PMID: 39456544.
10. Chaftari AM, Dagher H, Hachem R, Jiang Y, Lamie P, Wilson Dib R, John T, Haddad A, Philip A, Alii S, Mulanovich P, Yuan Y, Chaftari P, Raad I. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother 79(10):2543-2553, 2024. e-Pub 2024. PMID: 39092963.
11. Gerges BZ, Rosenblatt J, Truong YL, Raad II. Polygalacturonic acid partially inhibits matrix metalloproteinases and dehydration in wounds. Wounds 36(7):216-220, 2024. e-Pub 2024. PMID: 39110944.
12. Gerges B, Rosenblatt J, Truong YL, Jiang Y, Shelburne SA Sr, Chaftari AM, Hachem R, Raad I Sr. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC Antimicrob Resist 6(2):dlae060, 2024. e-Pub 2024. PMID: 38601790.
13. Haddad AJ, Hachem RY, Moussa M, Jiang Y, Dagher HR, Chaftari P, Chaftari AM, Raad I. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers (Basel) 16(5), 2024. e-Pub 2024. PMID: 38473412.
14. Gerges B, Rosenblatt J, Shellburne SA, Chaftari AM, Hachem R, Raad I. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist 5(6):dlad132, 2023. e-Pub 2023. PMID: 38089460.
15. Szvalb AD, Marten C, Cain K, Taylor JS, Huang SY, Jiang Y, Raad II, Viola GM. Percutaneous Nephrostomy Catheter-Related Infections in Patients with Gynaecological Cancers: A Multidisciplinary Algorithmic Approach. J Hosp Infect 141:99-106, 2023. e-Pub 2023. PMID: 37696471.
16. Gerges, B, Rosenblatt, J, Jiang, Y, Raad, I. Comparative Effectiveness and Persistence of Antimicrobial Durability in Dry and Wet States of a Novel Antimicrobial Surface Disinfectant. Applied Microbiology 3(2):549-561, 2023. e-Pub 2023.
17. Gerges B, Rolston K, Shelburne SA, Rosenblatt J, Prince R, Raad I. The in vitro activity of delafloxacin and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist 5(2):dlad034, 2023. e-Pub 2023. PMID: 36994231.
18. Rolston K, Gerges B, Nesher L, Shelburne SA, Prince R, Raad I. In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist 5(2):dlad020, 2023. e-Pub 2023. PMID: 36875177.
19. Viola GM, Szvalb AD, Malek AE, Chaftari AM, Hachem R, Raad II. Prevention of device-related infections in patients with cancer: Current practice and future horizons. CA Cancer J Clin 73(2):147-163, 2023. e-Pub 2023. PMID: 36149820.
20. Dagher H, Chaftari AM, Subbiah IM, Malek AE, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes-Gibby C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Chaftari P, Hachem R, Raad II. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife 12, 2023. e-Pub 2023. PMID: 36748905.
21. Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fernández Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (DCODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship. Elife 12, 2023. e-Pub 2023. PMID: 36715684.
22. Batista MV, Ussetti MP, Jiang Y, Neofytos D, Cortez AC, Feriani D, Schmidt-Filho J, França-Silva ILA, Raad I, Hachem R. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study. J Fungi (Basel) 9(2), 2023. e-Pub 2023. PMID: 36836281.
23. Dagher H, Chaftari AM, Mulanovich P, Jiang Y, Hachem R, Malek AE, Borjan J, Viola GM, Raad I. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. Elife 11, 2022. e-Pub 2022. PMID: 36541589.
24. Torres HA, Angelidakis G, Jiang Y, Economides M, Mustafayev K, Yibirin M, Orlowski R, Champlin R, Verstovsek S, Raad I. Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies. Medicine (Baltimore) 101(37):e30608, 2022. e-Pub 2022. PMID: 36123927.
25. Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Á G, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (DCODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv, 2022. e-Pub 2022. PMID: 36097568.
26. Chaftari AM, Hachem R, Malek AE, Mulanovich VE, Szvalb AD, Jiang Y, Yuan Y, Ali S, Deeba R, Chaftari P, Raad I. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients with Hematological Malignancies. Open Forum Infect Dis 9(6):ofac079, 2022. e-Pub 2022. PMID: 35663286.
27. Gerges BZ, Rosenblatt J, Truong YL, Reitzel RA, Raad I. Review of allergic reactions from use of chlorhexidine on medical products in clinical settings over 40 years: Risks and mitigations. Infect Control Hosp Epidemiol 43(6):775-789, 2022. e-Pub 2022. PMID: 34078513.
28. Rolston KVI, Gerges BZ, Reitzel R, Shelburne SA, Aitken SL, Raad II, Prince RA. In vitro activity of imipenem/relebactam and comparator agents against clinical bacterial isolates from patients with cancer. J Glob Antimicrob Resist 29:1-6, 2022. e-Pub 2022. PMID: 35121163.
29. Dagher H, Hachem R, Chaftari AM, Jiang Y, Ali S, Deeba R, Shah S, Raad I. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J Fungi (Basel) 8(1), 2022. e-Pub 2022. PMID: 35050014.
30. Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med 10(23):8475-8482, 2021. e-Pub 2021. PMID: 34725958.
31. Reitzel RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, Raad II. Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms". Antimicrob Agents Chemother 65(12):e0198621, 2021. e-Pub 2021. PMID: 34787467.
32. Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola GM, Raad II. Impact of Checkpoint Inhibitor Immunotherapy Primarily Pembrolizumab on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis 73(9):e2697-e2704, 2021. e-Pub 2021. PMID: 32564081.
33. Hachem R, Parikh UM, Reitzel R, Rosenblatt J, Kaul A, Vargas-Cruz N, Hill L, Moore L, Meyer J, Chaftari AM, Gagea M, Balaji S, Raad II. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair Regen 29(5):830-842, 2021. e-Pub 2021. PMID: 33956391.
34. Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439240.
35. Malek AE, Adachi JA, Mulanovich VE, Sassine J, Raad II, McConn K, Seiler GT, Dhal U, Khawaja F, Chemaly RF. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transpl Infect Dis 23(4):e13606, 2021. e-Pub 2021. PMID: 33755273.
36. Awadh H, Chaftari AM, Khalil M, Fares J, Jiang Y, Deeba R, Ali S, Hachem R, Raad II. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infect Dis 21(1):643, 2021. e-Pub 2021. PMID: 34225651.
37. Ariza-Heredia EJ, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and Identification of Clusters of Health Care Workers with COVID-19: Multidimensional Interventions at a Comprehensive Cancer Center. Infect Control Hosp Epidemiol 42(7):1-21, 2021. e-Pub 2021. PMID: 33183368.
38. Malek AE, Dagher H, Hachem R, Chaftari AM, Raad II. Is a single dose of mRNA vaccine sufficient for COVID-19 Survivors?. J Med Virol 93(7):4083-4084, 2021. e-Pub 2021. PMID: 33666244.
39. Khalil M, Chaftari AM, Dagher H, Rosenblatt J, Jiang Y, Reitzel R, Hachem R, Ginsberg CH, Raad I. Efficacy of a nitroglycerin-citrate-ethanol lock solution in maintaining central venous catheter patency and preventing thrombotic occlusions in cancer patients. Throm Res 201:60-62, 2021. e-Pub 2021. PMID: 33639387.
40. Kaseb AO, Mohamed YI, Malek AE, Raad II, Altameemi L, Li D, Kaseb OA, Kaseb SA, Selim A, Ma Q. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens 10(3), 2021. e-Pub 2021. PMID: 33809851.
41. Axell-House DB, Wurster S, Jiang Y, Kyvernitakis A, Lewis RE, Tarrand JJ, Raad II, Kontoyiannis DP. Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J Fungi (Basel) 7(3), 2021. e-Pub 2021. PMID: 33802827.
42. Maertens JA, Rahav G, Lee DG, Ponce-de-León A, Ramírez Sánchez IC, Klimko N, Sonet A, Haider S, Diego Vélez J, Raad I, Koh LP, Karthaus M, Zhou J, Ben-Ami R, Motyl MR, Han S, Grandhi A, Waskin H, investigators S. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet 397(10273):499-509, 2021. e-Pub 2021. PMID: 33549194.
43. Maertens JA, Rahav G, D-G L, Ponce-de-León A, Ramírez Sánchez IC, Klimko N, Sonet A, Haider S, Vélez JD, Raad I, L-P K, Karthaus M, Zhou J, Ben-Ami R, Motyl MR, Han S, Grandhi A, Waskin H. Posaconazole versus voriconazole for the primary treatment of invasive aspergillosis: a non-inferiority phase 3 randomised controlled trial. Lancet 397. e-Pub 2021.
44. Husni R, Chrabieh R, Dib RW, Vazquez J, Guimaraes T, Fernández A, Khoury R, Asmar L, Khazen G, Samaha N, Raad I, Hachem R. Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study. Mediterr J Hematol Infect Dis 13(1):e2021031, 2021. e-Pub 2021. PMID: 34007419.
45. Gerges BZ, Rosenblatt J, Truong YL, Reitzel RA, Hachem R, Raad II. Enhanced biofilm eradication and reduced cytotoxicity of a novel polygalacturonic and caprylic acid wound ointment compared with common antiseptic ointments. Biomed Res Int 2021:2710484, 2021. e-Pub 2021. PMID: 33708989.
46. Khalil M, Karimzad K, Durand JB, Malek AE, Raad II, Viola GM. Prevention of Cardiac Implantable Electronic Device-Related Infection in Patients With Cancer: The Role of a Comprehensive Prophylactic Bundle Approach That Includes the Antimicrobial Mesh. Open Forum Infect Dis 7(11):ofaa433, 2020. e-Pub 2020. PMID: 33204750.
47. Malek AE, Raad II, Jabbour E. Cancer and COVID-19. Lancet 396(10257):1066-1067, 2020. e-Pub 2020. PMID: 33038963.
48. John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95(9):2038-2040, 2020. e-Pub 2020. PMID: 32861345.
49. Reitzel RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, Raad II. Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms". Antimicrob Agents Chemother 64(7), 2020. e-Pub 2020. PMID: 32576597.
50. Malek AE, Raad II. Preventing catheter-related infections in cancer patients: a review of current strategies. Expert Rev Anti Infect Ther 18(6):531-538, 2020. e-Pub 2020. PMID: 32237923.
51. Shelburne SA, Dib RW, Endres BT, Reitzel R, Li X, Kalia A, Sahasrabhojane P, Chaftari AM, Hachem R, Vargas-Cruz NS, Jiang Y, Garey K, Fowler VG, Holland TL, Gu J, Miller W, Sakurai A, Arias CA, Aitken SL, Greenberg DE, Kim J, Flores AR, Raad I. Whole genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteremia is caused by a limited number of closely related sequence types. Clin Microbiol Infect 26(5):646.e1-646.e8, 2020. e-Pub 2020. PMID: 31639470.
52. Rolston KVI, Gerges B, Shelburne S, Aitken SL, Raad I, Prince RA. Activity of Cefiderocol and Comparators against Isolates from Cancer Patients. Antimicrob Agents Chemother 64(5), 2020. e-Pub 2020. PMID: 32071053.
53. Reitzel RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, Raad II. Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution is highly effective in vitro for Eradication of Candida auris Biofilms. Antimicrob Agents Chemother 64(4), 2020. e-Pub 2020. PMID: 31932380.
54. Malek AE, Nieto Y, Szvalb AD, Siddiqui S, Shafi MA, Hwang JP, Raad II, Torres HA. Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib. Clin Lymphoma Myeloma Leuk 20(3):e124-e127, 2020. e-Pub 2020. PMID: 31932250.
55. Reitzel RA, Rosenblatt J, Gerges BZ, Jarjour A, Fernandez-Cruz A, Raad II. The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review. JAC Antimicrob Resist 2(1):dlaa002, 2020. e-Pub 2020. PMID: 34222960.
56. Dib RW, Khalil M, Fares J, Hachem RY, Jiang Y, Dandachi D, Chaftari AM, Raad II. Invasive Pulmonary Aspergillosis: Comparative Analysis in Cancer Patients with Underlying Haematologic Malignancies Versus Solid Tumors. J Hosp Infect 104(3):358-364, 2020. e-Pub 2020. PMID: 31585141.
57. Malek AE, Gutierrez C, Mulanovich VE, Botdorf J, Chemaly RF, Shah S, McCall BM, Melancon JT, McConn KK, Borjan J, Raad II, Burger JA, Garcia-Manero G, Adachi JA. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis 12(1):e2020044, 2020. e-Pub 2020. PMID: 32670522.
58. Fares J, Khalil M, Chaftari AM, Hachem R, Jiang Y, Kantarjian HM, Raad II. Impact of catheter management on clinical outcome in adult cancer patients with gram-negative bacteremia. Open Forum Infect Dis 6(10):ofz357, 2019. e-Pub 2019. PMID: 31660336.
59. Tahtouh R, Wardi L, Sarkis R, Hachem R, Raad I, El Zein N, Hilal G. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines. Cell Mol Biol (Noisy-le-grand) 65(7):26-33, 2019. e-Pub 2019. PMID: 31880514.
60. Chaftari AM, Viola GM, Rosenblatt J, Hachem R, Raad I. Advances in the prevention and management of central-line-associated bloodstream infections: The role of chelator-based catheter locks. Infect Control Hosp Epidemiol 40(9):1-10, 2019. e-Pub 2019. PMID: 31230604.
61. Taremi M, Artau A, Foolad F, Berlin S, White C, Jiang Y, Raad I, Adachi J. Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients. J Allergy Clin Immunol Pract 7(7):2185-2191.e1, 2019. e-Pub 2019. PMID: 30928660.
62. Reitzel RA, Rosenblatt J, Chaftari AM, Raad II. Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Meta-Analysis. JPEN J Parenter Enteral Nutr 43(7):832-851, 2019. e-Pub 2019. PMID: 31172542.
63. Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother 74(7):1904-1910, 2019. e-Pub 2019. PMID: 31225606.
64. Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad II. Nitroglycerin-Citrate-Ethanol (NiCE) Catheter Lock Solution is Highly Effective for in vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother 63(7), 2019. e-Pub 2019. PMID: 31036689.
65. Viola GM, Rolston KV, Butler C, Selber J, Reece G, Clemens M, Villa M, Raad II, Baumann D. Evaluation of Current Perioperative Antimicrobial Regimens for the Prevention of Surgical Site Infections in Breast Implant-based Reconstructive Surgeries. Plast Reconstr Surg Glob Open 7(7):e2342, 2019. e-Pub 2019. PMID: 31942364.
66. Rolston KVI, Jamal M, Nesher L, Raad I, Rice SA, Rybak MJ, Prince RA. Bactericidal activity of ceftaroline, vancomycin, daptomycin against methicillin-resistant staphylococcus aureus isolates from cancer patients. J Glob Antimicrob Resist 17:16-18, 2019. e-Pub 2019. PMID: 30844496.
67. Shomali W, Hachem R, Chaftari AM, Bahu R, El Helou G, Jiang Y, Hanania AN, Reitzel R, Raad I. Corrigendum to "Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?" [Diagn Microbiol Infect Dis 2019;76(2):158-161]. Diagn Microbiol Infect Dis 94(1):105, 2019. e-Pub 2019. PMID: 30852051.
68. Rosenblatt J, Vargas-Cruz N, Reitzel RA, Raad II. Assessment of the potential for inducing resistance in multidrug resistant organisms from exposure to minocycline, rifampin and chlorhexidine used to treat intravascular devices. Antimicrob Agents Chemother 63(5), 2019. e-Pub 2019. PMID: 30833430.
69. Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF. Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Open Forum Infect Dis 6(4):ofz138, 2019. e-Pub 2019. PMID: 31024975.
70. Szvalb AD, El Haddad H, Rolston KV, Sabir SH, Jiang Y, Raad II, Viola GM. Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection 47(2):239-245, 2019. e-Pub 2019. PMID: 30406481.
71. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol 114(2):250-257, 2019. e-Pub 2019. PMID: 30410039.
72. Debiane L, Reitzel R, Rosenblatt J, Gagea M, Chavez MA, Adachi R, Grosu HB, Sheshadri A, Hill LR, Raad I, Ost DE. A Design-Based Stereologic Method to Quantify the Tissue Changes Associated with a Novel Drug-Eluting Tracheobronchial Stent. Respiration 98(1):1-10, 2019. e-Pub 2019. PMID: 30799409.
73. Hachem R, Batista MV, Kanj SS, El Zein S, Haddad S, Jiang Y, Mori N, Vanderson R, Chaftari AM, Raad I. International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. Mediterr J Hematol Infect Dis 11(1):e2019003, 2019. e-Pub 2019. PMID: 30671209.
74. Vargas-Cruz N, Rosenblatt J, Reitzel RA, Chaftari AM, Hachem R, Raad I. Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs). Biomed Res Int 2019:2869039, 2019. e-Pub 2019. PMID: 31976318.
75. Malek AE, Fares JE, Raad II, Ericsson C. Pasteurella multocida vertebral osteomyelitis, myositis and epidural abscess in a diabetic cirrhotic patient. IDCases 18:e00630, 2019. e-Pub 2019. PMID: 31516829.
76. Dib RW, Hachem RY, Chaftari AM, Ghaly F, Jiang Y, Raad I. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis 18(1):656, 2018. e-Pub 2018. PMID: 30545320.
77. Raad II, Chaftari AM, Dib RW, Graviss EA, Hachem R. Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East. Infect Control Hosp Epidemiol 39(10):1-7, 2018. e-Pub 2018. PMID: 30099975.
78. Wilson Dib R, Chaftari AM, Hachem RY, Yuan Y, Dandachi D, Raad II. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis 5(10):ofy249, 2018. e-Pub 2018. PMID: 30377625.
79. Dandachi D, Wilson Dib R, Fernández-Cruz A, Jiang Y, Chaftari AM, Hachem R, Raad I. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med:1-8. e-Pub 2018. PMID: 30230385.
80. Raad II, Chaftari AM, Torres HA, Ayoub EM, Narouz LI, Bartek J, Hachem R. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol 10(9):549-557, 2018. e-Pub 2018. PMID: 30310533.
81. Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J, Sims M, Wray D, Zervos M, Fowler VG, Investigators SB. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. JAMA 320(12):1249-1258, 2018. e-Pub 2018. PMID: 30264119.
82. El Haddad H, Chaftari AM, Hachem R, Chaftari P, Raad II. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin with Emphasis in Patients with Cancer. Clin Infect Dis 67(6):971-977, 2018. e-Pub 2018. PMID: 29668936.
83. Rolston KVI, Reitzel R, Vargas-Cruz N, Shelburne SA, Raad II, Prince RA. In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer. Diagn Microbiol Infect Dis 91(4):351-353, 2018. e-Pub 2018. PMID: 29661529.
84. Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses. Clin Infect Dis 67(3):398-406, 2018. e-Pub 2018. PMID: 29546356.
85. Folan SA, Marx KR, Tverdek FP, Raad I, Mulanovich VE, Tarrand JJ, Shelburne SA, Aitken SL. Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia. Open Forum Infect Dis 5(7):ofy167, 2018. e-Pub 2018. PMID: 30090838.
86. Hachem R, Kanj S, Hamerschlak N, Saad H, Assir FF, Mori N, Jiang Y, Ghaly F, Chaftari AM, Raad II. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections. Expert Rev Med Devices 15(6):461-466, 2018. e-Pub 2018. PMID: 29927699.
87. Chaftari AM, Hachem R, Jiang Y, Shah P, Hussain A, Hamal ZA, Yousif A, Jordan M, Michael M, Raad I. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infect Control Hosp Epidemiol 39(6):727-729, 2018. e-Pub 2018. PMID: 29770754.
88. El Haddad H, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep 8(1):6258, 2018. e-Pub 2018. PMID: 29674672.
89. Chaftari AM, Hachem R, Raad S, Jiang Y, Natividad E, Chaftari P, Raad I. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol 39(2):1-4, 2018. e-Pub 2018. PMID: 29331162.
90. Haddad HE, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep 8(1):1099, 2018. e-Pub 2018. PMID: 29348438.
91. Dib RW, Hachem R, Chaftari AM, Raad I. Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients. Mediterr J Hematol Infect Dis 10(1):e2018028, 2018. e-Pub 2018. PMID: 29755705.
92. Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, MLPS VI, Hepler DA, Waskin H, Kartsonis NA, Maertens J. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother 72(12):3406-3413, 2017. e-Pub 2017. PMID: 28961714.
93. Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, MLPS VI, Hepler DA, Waskin H, Kartsonis NA, Maertens J. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother 72(12):3501, 2017. e-Pub 2017. PMID: 29029280.
94. Zakhour R, Hachem R, Alawami HM, Jiang Y, Michael M, Chaftari AM, Raad I. Comparing catheter-related bloodstream infections in pediatric and adult cancer patients. Pediatr Blood Cancer 64(10), 2017. e-Pub 2017. PMID: 28409898.
95. Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, Chaftari AM, Raad II. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents 50(3):384-388, 2017. e-Pub 2017. PMID: 28694233.
96. Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Amin S, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28743701.
97. Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Sapna A, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother 61(7), 2017. e-Pub 2017. PMID: 28416559.
98. Vargas-Cruz N, Reitzel RA, Rosenblatt J, Jamal M, Szvalb AD, Chaftari AM, Hachem R, Raad I. Antimicrobial Percutaneous Nephrostomy Catheters for the prevention of Renal Infections: In vitro studies. Antimicrob Agents Chemother 61(6), 2017. e-Pub 2017. PMID: 28320713.
99. Hachem R, Reitzel R, Rolston K, Chaftari AM, Raad I. Antimicrobial Activities of Ceftazidime/Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother 61(4), 2017. e-Pub 2017. PMID: 28115350.
100. Rolston KVI, Jamal MA, Nesher L, Shelburne SA, Raad I, Prince RA. In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients. Int J Antimicrob Agents 49(4):416-421, 2017. e-Pub 2017. PMID: 28257904.
101. Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control 45(3):e34-e39, 2017. e-Pub 2017. PMID: 28254252.
102. Viola GM, Rosenblatt J, Raad II. Drug eluting antimicrobial vascular catheters: Progress and promise. Adv Drug Deliv Rev 112:35-47, 2017. e-Pub 2017. PMID: 27496702.
103. Rosenblatt J, Reitzel RA, Vargas-Cruz N, Chaftari AM, Hachem R, Raad II. Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia. J Fungi (Basel) 3(1), 2017. e-Pub 2017. PMID: 29371526.
104. Hilal G, Reitzel R, Al Hamal Z, Chaftari AM, Al Wohoush I, Jiang Y, Hachem R, Raad II. Novel plasma telomerase detection method to improve cancer diagnostic assessment. PLoS One 12(5):e0174266, 2017. e-Pub 2017. PMID: 28467443.
105. Rosenblatt J, Reitzel RA, Viola GM, Vargas-Cruz N, Selber J, Raad I. Sodium Mercaptoethane Sulfonate Reduces Collagenolytic Degradation and Synergistically Enhances Antimicrobial Durability in an Antibiotic-Loaded Biopolymer Film for Prevention of Surgical-Site Infections. Biomed Res Int 2017:3149536, 2017. e-Pub 2017. PMID: 29238713.
106. Mahfouz N, Tahtouh R, Alaaeddine N, El Hajj J, Sarkis R, Hachem R, Raad I, Hilal G. Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors. PLoS One 12(6):e0179202, 2017. e-Pub 2017. PMID: 28594907.
107. Rosenblatt J, Reitzel RA, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm. Front Microbiol 8:1999, 2017. e-Pub 2017. PMID: 29093703.
108. Aboshady I, Raad I, Vela D, Hassan M, Aboshady Y, Safi HJ, Buja LM, Khalil KG. Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft. J Vasc Surg 64(6):1805-1814, 2016. e-Pub 2016. PMID: 26626182.
109. Zakhour R, Chaftari AM, Raad II. Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis 16(11):e241-e250, 2016. e-Pub 2016. PMID: 27788992.
110. Yousif A, Chaftari AM, Michael M, Jordan M, Al Hamal Z, Hussain A, Elizabeth N, Jiang Y, Hachem R, Raad I. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. Am J Infect Control 44(9):1037-40, 2016. e-Pub 2016. PMID: 26897695.
111. Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control 44(9):1016-21, 2016. e-Pub 2016. PMID: 27158088.
112. Reitzel RA, Rosenblatt J, Hirsh-Ginsberg C, Murray K, Chaftari AM, Hachem R, Raad I. Optimized Nitroglycerin-Citrate-Ethanol (NiCE), non-antibiotic, antimicrobial, catheter lock solution for prevention of central line associated blood stream infections (CLABSI) - an in vitro assessment of antimicrobial efficacy. Antimicrob Agents Chemother 60(9):5175-81, 2016. e-Pub 2016. PMID: 27297475.
113. Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. J Natl Compr Canc Netw 14(9):1185-8, 2016. e-Pub 2016. PMID: 27587628.
114. Chaftari AM, Jordan M, Hachem R, Al Hamal Z, Jiang Y, Yousif A, Garoge K, Deshmukh P, Raad I. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury. Am J Infect Control 44(8):931-4, 2016. e-Pub 2016. PMID: 27112370.
115. Viola GM, Selber JC, Crosby M, Raad II, Butler CE, Villa MT, Kronowitz SJ, Clemens MW, Garvey P, Yang W, Baumann DP. Salvaging the Infected Breast Tissue Expander: A Standardized Multidisciplinary Approach. Plast Reconstr Surg Glob Open 4(6):e732, 2016. e-Pub 2016. PMID: 27482480.
116. Raad I, Chaftari AM, Zakhour R, Jordan M, Al Hamal Z, Jiang Y, Yousif A, Garoge K, Mulanovich V, Viola GM, Kanj S, Pravinkumar E, Rosenblatt J, Hachem R. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother 60(6):3426-32, 2016. e-Pub 2016. PMID: 27001822.
117. Cornely OA, Duarte RF, Haider S, Chandrasekar P, Helfgott D, Jiménez JL, Candoni A, Raad I, Laverdiere M, Langston A, Kartsonis N, Van Iersel M, Connelly N, Waskin H. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. J Antimicrob Chemother 71(6):1747, 2016. e-Pub 2016. PMID: 26960721.
118. Viola GM, Baumann DP, Mohan K, Selber J, Garvey P, Reece G, Raad II, Rolston KV, Crosby MA. Improving Antimicrobial Regimens for the Treatment of Breast Tissue Expander-Related Infections. Plast Reconstr Surg Glob Open 4(5):e704, 2016. e-Pub 2016. PMID: 27579229.
119. Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari AM, Raad II. Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism. Medicine (Baltimore) 95(14):e2691, 2016. e-Pub 2016. PMID: 27057825.
120. Cornely OA, Duarte RF, Haider S, Chandrasekar P, Helfgott D, Jiménez JL, Candoni A, Raad I, Laverdiere M, Langston A, Kartsonis N, Van Iersel M, Connelly N, Waskin H. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. J Antimicrob Chemother 71(3):718-26, 2016. e-Pub 2016. PMID: 26612870.
121. Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 387(10020):760-9, 2016. e-Pub 2016. PMID: 26684607.
122. Li Y, Zhang P, Cai W, Rosenblatt JS, Raad II, Xu D, Gu T. Glyceryl trinitrate and caprylic acid for the mitigation of the Desulfovibrio vulgaris biofilm on C1018 carbon steel. World J Microbiol Biotechnol 32(2):23, 2016. e-Pub 2016. PMID: 26745983.
123. Rosenblatt J, Viola GM, Reitzel RA, Jamal MA, Crosby MA, Raad I. Novel in situ liquefying antimicrobial wrap for preventing tissue expander infections following breast reconstructive surgeries. J Biomed Mater Res B Appl Biomater 104(2):369-74, 2016. e-Pub 2016. PMID: 25809618.
124. Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M. Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting. Infect Control Hosp Epidemiol 36(12):1461-3, 2015. e-Pub 2015. PMID: 26329908.
125. Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwehr B, Mulanovich V, Gagel A, Reitzel R, Yousif A, Jiang Y, Raad I. Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer: A Case Control Study. Antimicrob Agents Chemother. e-Pub 2015. PMID: 26482312.
126. Jamal MA, Hachem RY, Rosenblatt J, McArthur MJ, Felix E, Jiang Y, Tailor RC, Raad I. In Vivo Biocompatibility and In Vitro Efficacy of Antimicrobial Gendine-Coated Central Catheters. Antimicrob Agents Chemother 59(9):5611-8, 2015. e-Pub 2015. PMID: 26124171.
127. Jamal MA, Garoge K, Rosenblatt JS, Hachem RY, Raad II. Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use. Antimicrob Agents Chemother 59(8):4397-402, 2015. e-Pub 2015. PMID: 25941227.
128. Hachem R, Reitzel R, Jiang Y, Chemaly RF, Han XY. The performance of quantitative real-time polymerase chain reaction and galactomannan for invasive fungal infections in patients with hematologic malignancies. Fungal Genom Biol(4):123, 2015. e-Pub 2015.
129. Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents 45(3):283-8, 2015. e-Pub 2015. PMID: 25455847.
130. Rosenblatt J, Reitzel RA, Raad I. Caprylic Acid and Glyceryl Trinitrate Combination for Eradication of Biofilm. Antimicrob Agents Chemother 59(3):1786-8, 2015. e-Pub 2015. PMID: 25534725.
131. Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol 64(Pt 2):191-4, 2015. e-Pub 2015. PMID: 25627208.
132. Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly R. Non-inferiority of pulsed xenon ultraviolet light versus bleach versus for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile isolation rooms. J Med Microbiol. e-Pub 2015. PMID: 25587076.
133. Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and Sporadic Cases of Herbaspirillum spp. Infections in Patients with Cancer. Clin Infect Dis 60(1):48-54, 2015. e-Pub 2015. PMID: 25216687.
134. Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw 13(1):41-50, 2015. e-Pub 2015. PMID: 25583768.
135. Chaftari AM, Hachem R, Reitzel R, Jordan M, Jiang Y, Yousif A, Garoge K, Deshmukh P, Al Hamal Z, Jabbour J, Hanania A, Raad S, Jamal M, Raad I. Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS One 10(7):e0130999, 2015. e-Pub 2015. PMID: 26148092.
136. Tahtouh R, Azzi AS, Alaaeddine N, Chamat S, Bouharoun-Tayoun H, Wardi L, Raad I, Sarkis R, Antoun NA, Hilal G. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study. PLoS One 10(3):e0119512, 2015. e-Pub 2015. PMID: 25822740.
137. Yousif A, Jamal MA, Raad I. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol 830:157-79, 2015. e-Pub 2015. PMID: 25366227.
138. Debiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, Chaftari AM, Jabbour J, Al Shuaibi M, Hanania A, Pravinkumar SE, Schuetz P, Raad I. The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically Ill Patients With Cancer. Crit Care Med 42(12):2500-7, 2014. e-Pub 2014. PMID: 25083975.
139. Raad I, Chaftari AM. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clin Infect Dis 59 Suppl 5:S340-3, 2014. e-Pub 2014. PMID: 25352628.
140. Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, Ramos E, Jiang Y, Chaftari AM, Raad II. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother 69(11):3148-55, 2014. e-Pub 2014. PMID: 25006241.
141. Shelburne SA, Chaftari AM, Jamal M, Al Wohoush I, Jiang Y, Abughazaleh S, Cairo J, Raad S, Debiane L, Raad I. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer. Am J Infect Control 42(10):1127-9, 2014. e-Pub 2014. PMID: 25278410.
142. Jamal MA, Rosenblatt J, Jiang Y, Hachem R, Chaftari AM, Raad II. Prevention of Transmission of Multidrug-Resistant Organisms during Catheter Exchange using Antimicrobial Catheters. Antimicrob Agents Chemother 58(9):5291-6, 2014. e-Pub 2014. PMID: 24957841.
143. El Zakhem A, Chaftari AM, Bahu R, El Helou G, Shelburne S, Jiang Y, Hachem R, Raad I. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med 46(3):163-8, 2014. e-Pub 2014. PMID: 24491173.
144. Szvalb AD, Raad II, Weinberg JS, Suki D, Mayer R, Viola GM. Ommaya reservoir-related infections: Clinical manifestations and treatment outcomes. J Infect 68(3):216-24, 2014. e-Pub 2014. PMID: 24360921.
145. Reitzel R, Rosenblatt J, Jiang Y, Hachem R, Raad I. Disposable gendine antimicrobial gloves for preventing transmission of pathogens in health care settings. Am J Infect Control 42(1):55-9, 2014. e-Pub 2014. PMID: 24388469.
146. Viola GM, Raad II, Rolston KV. Breast tissue expander-related infections: perioperative antimicrobial regimens. Infect Control Hosp Epidemiol 35(1):75-81, 2014. e-Pub 2014. PMID: 24334802.
147. Wardi L, Alaaeddine N, Raad I, Sarkis R, Serhal R, Khalil C, Hilal G. Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532. Cancer Cell Int 14:60, 2014. e-Pub 2014. PMID: 25089119.
148. Chaftari AM, El Zakhem A, Jamal MA, Jiang Y, Hachem R, Raad I. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis 14(1):518, 2014. e-Pub 2014. PMID: 25253042.
149. Rosenblatt J, Reitzel R, Jiang Y, Hachem R, Raad I. Insights on the role of antimicrobial cuffed endotracheal tubes in preventing transtracheal transmission of VAP pathogens from an in vitro model of microaspiration and microbial proliferation. Biomed Res Int 2014:120468, 2014. e-Pub 2014. PMID: 24818125.
150. Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II. Prevention of Gram-Negative Bacterial Biofilm on Minocycline/Rifampin impregnated catheters sequentially coated with Chlorhexidine. Antimicrob Agents Chemother 58(2):1179-82, 2014. e-Pub 2014. PMID: 24165191.
151. Nassani N, Khayat G, Raad I, Jiang Y, Alaaeddine N, Hilal G. Telomerase as a potential marker for inflammation and cancer detection in bronchial washing: A prospective study. Clin Biochem 46(16-17):1701-4, 2013. e-Pub 2013. PMID: 23899579.
152. Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care 19(5):453-60, 2013. e-Pub 2013. PMID: 23817026.
153. Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob Agents Chemother 57(8):3555-60, 2013. e-Pub 2013. PMID: 23669393.
154. Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol 24(7):1873-9, 2013. e-Pub 2013. PMID: 23519997.
155. Viola GM, Rosenblatt J, Raad II, Darouiche RO. Comparison of bacterial adherence to titanium versus polyurethane for cardiac implantable electronic devices. Am J Cardiol 111(12):1764-6, 2013. e-Pub 2013. PMID: 23523061.
156. Shomali W, Hachem R, Chaftari AM, Bahu R, Helou GE, Jiang Y, Hanania A, Reitzel R, Raad I. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?. Diagn Microbiol Infect Dis 76(2):158-61, 2013. e-Pub 2013. PMID: 23578976.
157. Al Shuaibi M, Bahu RR, Chaftari AM, Al Wohoush I, Shomali W, Jiang Y, Debiane L, Raad S, Jabbour J, Al Akhrass F, Hachem RY, Raad I. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis 56(7):943-50, 2013. e-Pub 2013. PMID: 23288950.
158. El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, Tarrand J, Raad II. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis 56(6):843-6, 2013. e-Pub 2013. PMID: 23254418.
159. Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DP. Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment. Microb Pathog 55:16-20, 2013. e-Pub 2013. PMID: 23232438.
160. El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13(2):166-74, 2013. e-Pub 2013. PMID: 23347634.
161. Raad I, Rosenblatt J, Reitzel R, Jiang Y, Dvorak T, Hachem R. Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother 57(1):586-8, 2013. e-Pub 2013. PMID: 23070163.
162. Bahu R, Chaftari AM, Hachem RY, Ahrar K, Shomali W, El Zakhem A, Jiang Y, AlShuaibi M, Raad II. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol 189(1):130-5, 2013. e-Pub 2013. PMID: 23164390.
163. Shomali W, Hachem R, Chaftari AM, Jiang Y, Bahu R, Jabbour J, Raad S, Al Shuaibi M, Al Wohoush I, Raad I. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?. Cancer 118(23):5823-9, 2012. e-Pub 2012. PMID: 22605389.
164. Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis 206(9):1367-71, 2012. e-Pub 2012. PMID: 22927454.
165. Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza a (H1N1) infection in patients with solid tumors in 3 countries: Early therapy improves outcomes. Cancer 118(18):4627-33, 2012. e-Pub 2012. PMID: 22359314.
166. Aboshady I, Raad I, Shah AS, Vela D, Dvorak T, Safi HJ, Buja LM, Khalil KG. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection. J Vasc Surg 56(3):794-801, 2012. e-Pub 2012. PMID: 22579134.
167. Chaftari AM, Hachem RY, Ramos E, Kassis C, Campo M, Jiang Y, Prince RA, Wang W, Raad II. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation 94(3):302-8, 2012. e-Pub 2012. PMID: 22814329.
168. Borchardt RA, Raad I. Bloodstream infections: the risks and benefits of intravascular catheters. JAAPA 25(8):21-2, 2012. e-Pub 2012. PMID: 22928272.
169. Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study. J Clin Virol 54(3):218-22, 2012. e-Pub 2012. PMID: 22459004.
170. Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J 31(4):373-8, 2012. e-Pub 2012. PMID: 22228234.
171. Lee LD, Hachem RY, Berkheiser M, Hackett B, Jiang Y, Raad II. Hospital environment and invasive aspergillosis in patients with hematologic malignancy. Am J Infect Control 40(3):247-9, 2012. e-Pub 2012. PMID: 21856045.
172. Xu D, Wen J, Fu W, Gu T, Raad I. D: -amino acids for the enhancement of a binary biocide cocktail consisting of THPS and EDDS against an SRB biofilm. World J Microbiol Biotechnol 28(4):1641-6, 2012. e-Pub 2012. PMID: 22805946.
173. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale PS, Davila M, Raad II. Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis 54(5):740-2, 2012. e-Pub 2012. PMID: 22322272.
174. Wen J, Xu D, Gu T, Raad I. A green triple biocide cocktail consisting of a biocide, EDDS and methanol for the mitigation of planktonic and sessile sulfate-reducing bacteria. World J Microbiol Biotechnol 28(2):431-5, 2012. e-Pub 2012. PMID: 22806837.
175. Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. Improved antibiotic impregnated catheters with extended spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56(2):935-41, 2012. e-Pub 2012. PMID: 22123686.
176. Al Akhrass F, Al Wohoush I, Chaftari AM, Reitzel R, Jiang Y, Ghannoum M, Tarrand J, Hachem R, Raad I. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One 7(3):e32945, 2012. e-Pub 2012. PMID: 22427914.
177. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 17(10):1329-36, 2012. e-Pub 2012. PMID: 22707509.
178. Xu D, Wen J, Gu T, Raad I. Biocide cocktail consisting of glutaraldehyde, ethylene diamine disuccinate (EDDS), and methanol for the mitigation of souring and biocorrosion. Corrosion 68(11):994-1002, 2012. e-Pub 2012.
179. Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect 17(11):1711-6, 2011. e-Pub 2011. PMID: 21595787.
180. Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad I. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 17(9):1651-8, 2011. e-Pub 2011. PMID: 21888790.
181. Campo M, Hachem R, Jiang Y, Dvorak T, Carrillo-Marquez M, Hulten K, Chemaly RF, Raad I. Panton valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant staphylococcus aureus (MRSA) infections. Medicine (Baltimore) 90(5):312-8, 2011. e-Pub 2011. PMID: 21862937.
182. Chemaly RF, Rathod DB, Sikka MK, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Trenholme G, Raad I. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: a multi-state report. Am J Infect Control 39(6):521-4, 2011. e-Pub 2011. PMID: 21492963.
183. Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer 117(11):2551-8, 2011. e-Pub 2011. PMID: 24048803.
184. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, (HICPAC) (Appendix) HICPAC. Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis 52(9):1087-99, 2011. e-Pub 2011. PMID: 21467014.
185. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Advisory Committee HICP. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39(4 Suppl 1):S1-34, 2011. e-Pub 2011. PMID: 21511081.
186. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Committee (HICPAC) HICPA. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162-93, 2011. e-Pub 2011. PMID: 21460264.
187. Al Wohoush I, Rivera J, Cairo J, Hachem R, Raad I. Comparing Clinical and Microbiological Methods for the Diagnosis of True Bacteremia among Patients with Multiple Blood Cultures Positive for Coagulase-Negative Staphylococci. Clin Microbiol Infect 17(4):569-71, 2011. e-Pub 2011. PMID: 20854425.
188. Raad I, Bodey GP. Novel antimicrobial catheter lock solution: a new direction in which chelators replace heparin. Crit Care Med 39(4):875-6, 2011. e-Pub 2011. PMID: 21613829.
189. Raad II, Mohamed JA, Reitzel RA, Jiang Y, Dvorak TL, Ghannoum MA, Hachem RY, Chaftari AM. The Prevention of Biofilm Colonization by Multidrug-Resistant Pathogens that Cause Ventilator-Associated Pneumonia with Antimicrobial-Coated Endotracheal Tubes. Biomaterials 32(11):2689-94, 2011. e-Pub 2011. PMID: 21295343.
190. Kassis C, Hachem R, Raad II, Perego CA, Dvorak T, Hulten KG, Frenzel E, Thomas G, Chemaly RF. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control 39(2):112-7, 2011. e-Pub 2011. PMID: 20817317.
191. Stibich M, Stachowiak J, Tanner B, Berkheiser M, Moore L, Raad I, Chemaly RF. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol 32(3):286-8, 2011. e-Pub 2011. PMID: 21460515.
192. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52(4):e56-93, 2011. e-Pub 2011. PMID: 21258094.
193. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Executive Summary: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52(4):427-31, 2011. e-Pub 2011. PMID: 21205990.
194. Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical Effectiveness and Risk of Emerging Resistance Associated with Prolonged Use of Antibiotic-Impregnated Catheters: More than 0.5 Million Catheter Days and 7 Years of Clinical Experience. Crit Care Med 39(2):245-51, 2011. e-Pub 2011. PMID: 21057308.
195. Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 16(7):1049-60, 2011. e-Pub 2011. PMID: 21659609.
196. Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. e-Pub 2010. PMID: 21157952.
197. Mihu CN, Kassis C, Ramos ER, Jiang Y, Hachem RY, Raad II. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?. Cancer 116(22):5290-6, 2010. e-Pub 2010. PMID: 20665889.
198. Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. Eur J Clin Microbiol Infect Dis 29(11):1387-94, 2010. e-Pub 2010. PMID: 20703506.
199. Al Wohoush I, Cairo J, Rangaraj G, Granwehr B, Hachem R, Raad I. Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol 10(10):1089-1091, 2010. e-Pub 2010. PMID: 20807036.
200. Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P, Study Group FM. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54(10):4446-50, 2010. e-Pub 2010. PMID: 20625156.
201. Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant 16(9):1265-71, 2010. e-Pub 2010. PMID: 20304082.
202. Hogan HL, Hachem RY, Neuhauser M, Raad II, Coyle E. Clinical experience of linezolid in bone marrow transplantation patients. J Pharm Pract 23(4):352-7, 2010. e-Pub 2010. PMID: 21507835.
203. Hogan HL, Hachem RY, Neuhauser M, Raad I, Coyle E. Clinical Experience of Linezolid in Bone Marrow Transplant Patients. Journal of Pharmacy Practice 23(4):352-357, 2010. e-Pub 2010.
204. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 36(2)(2):182-186, 2010. e-Pub 2010. PMID: 20452752.
205. Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore) 89(4):236-44, 2010. e-Pub 2010. PMID: 20616663.
206. Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis 14(7):e548-52, 2010. e-Pub 2010. PMID: 20005762.
207. Chemaly RF, Hachem RY, Husni RN, Bahna B, Rjaili GA, Waked A, Graviss L, Nebiyou Bekele B, Shah JN, Raad II. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol 17(6):1499-506, 2010. e-Pub 2010. PMID: 20127184.
208. Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Waked A, Graviss L, Bekele BN, Shah JN, Raad II. Erratum to: Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case-Control Study. Ann Surg Oncol. e-Pub 2010. PMID: 20224857.
209. Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967-973, 2010. e-Pub 2010. PMID: 20052728.
210. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 50(3):374-380, 2010. e-Pub 2010. PMID: 20038242.
211. Ghide S, Jiang Y, Hachem R, Chaftari AM, Raad I. Catheter-Related Corynebacterium Bacteremia: Should the Catheter Be Removed and Vancomycin Administered?. Eur J Clin Microbiol Infect Dis 29(2):153-6, 2010. e-Pub 2010. PMID: 20016995.
212. Chemaly RF, Rathod DB, Raad II. A tertiary care cancer center experience of the 2007 outbreak of Serratia marcescens bloodstream infection due to prefilled syringes. Infect Control Hosp Epidemiol 30(12):1237-8, 2009. e-Pub 2009. PMID: 19888846.
213. Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 53(12):5145-9, 2009. e-Pub 2009. PMID: 19805562.
214. Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 37(9):741-5, 2009. e-Pub 2009. PMID: 19487050.
215. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115(20):4745-52, 2009. e-Pub 2009. PMID: 19634156.
216. Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?. Clin Infect Dis 49(8):1187-94, 2009. e-Pub 2009. PMID: 19780661.
217. Blossom D, Noble-Wang J, Su J, Pur S, Chemaly R, Shams A, Jensen B, Pascoe N, Gullion J, Casey E, Hayden M, Arduino M, Budnitz DS, Raad I, Trenholme G, Srinivasan A. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med 169(18):1705-11, 2009. e-Pub 2009. PMID: 19822828.
218. Engelhard D, Akova M, Boeckh MJ, Freifeld A, Sepkowitz K, Viscoli C, Wade J, Raad I. Bacterial infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant 44(8):467-70, 2009. e-Pub 2009. PMID: 19861980.
219. Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I. Differentiating Coagulase-Negative Staphylococcal Bacteremia from Contamination Using Time to Positivity and Quantitative Blood Cultures Methods. J Clin Microbiol 47(10):3255-60, 2009. e-Pub 2009. PMID: 19692564.
220. Kassar R, Hachem R, Jiang Y, Chaftari AM, Raad I. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore) 88(5):279-83, 2009. e-Pub 2009. PMID: 19745686.
221. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1-45, 2009. e-Pub 2009. PMID: 19489710.
222. Venkatesh M, Rong L, Raad I, Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol 58(Pt 7):936-44, 2009. e-Pub 2009. PMID: 19502361.
223. Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore) 88(4):211-20, 2009. e-Pub 2009. PMID: 19593226.
224. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 48(8):1033-41, 2009. e-Pub 2009. PMID: 19267655.
225. Vigil KJ, Mulanovich VE, Chemaly RF, Tarrand J, Raad II, Adachi JA. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med 265(3):397-400, 2009. e-Pub 2009. PMID: 19019183.
226. Sipsas NV, Lewis RE, Raad II, Kontoyiannis DP. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. Int J Antimicrob Agents 34(1):95-8. e-Pub 2009. PMID: 19251404.
227. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 43(2):210-9. e-Pub 2009. PMID: 19193593.
228. Raad I. Making catheter-related bloodstream infections history: from the slogan to the serious strategy. Crit Care Med 37(2):789-91, 2009. e-Pub 2009. PMID: 19325393.
229. Reitzel RA, Dvorak TL, Hachem RY, Fang X, Jiang Y, Raad I. Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. Am J Infect Control 37(4):294-300. e-Pub 2009. PMID: 19155100.
230. Ramos ER, Hachem R, Youssef S, Fang X, Jiang Y, Raad I. The crucial role of catheters in micrococcal bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 30(1):83-5, 2009. e-Pub 2009. PMID: 19046050.
231. Wen J, Zhao K, Gu T, Raad II. A green biocide enhancer for the treatment of sulfate-reducing bacteria (SRB) biofilms on carbon steel surfaces using glutaraldehyde. International Biodeterioration & Biodegradation 63:1102-1106, 2009. e-Pub 2009.
232. Wen J, Zhao K, Gu T, Raad I. Chelators enhanced biocide inhibition of planktonic sulfate-reducing bacterial growth. World J Microbiol Biotechnol online publication, 2009. e-Pub 2009.
233. Engelhard D, Akova M, Boeckh MJ, Freifeld A, Sepkowitz K, Viscoli C, Wade J, Raad I. Bacterial infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant 44(8):467-480, 2009. e-Pub 2009.
234. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology 77(2):75-81, 2009. e-Pub 2009. PMID: 19571599.
235. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control 37(6):442-6. e-Pub 2008. PMID: 19118923.
236. Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X, Shukrallah B, Raad II. Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer. Infection 36(6):539-42, 2008. e-Pub 2008. PMID: 18726553.
237. Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sherertz RJ, Kontoyiannis DP. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 32(6):515-8, 2008. e-Pub 2008. PMID: 18783924.
238. Torres HA, Aguilera E, Safdar A, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect 14(12):1160-6. e-Pub 2008. PMID: 19046167.
239. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47(1):129-33. e-Pub 2008. PMID: 19005145.
240. Nguyen VT, Darbour N, Bayet C, Doreau A, Raad I, Phung BH, Dumontet C, Di Pietro A, Dijoux-Franca MG, Guilet D. Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. Fitoterapia 80(1):39-42. e-Pub 2008. PMID: 18940238.
241. Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control 36(9):656-60. e-Pub 2008. PMID: 18834742.
242. Hachem RY, Langston AA, Graybill JR, Perfect JR, Pedicone LD, Patino H, Raad II. Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment. J Antimicrob Chemother 62(6):1386-91. e-Pub 2008. PMID: 18835806.
243. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother 62(4):746-50, 2008. e-Pub 2008. PMID: 18653489.
244. Raad II. Commentary: zero tolerance for catheter-related bloodstream infections: the unnegotiable objective. Infect Control Hosp Epidemiol 29(10):951-3, 2008. e-Pub 2008. PMID: 18754737.
245. Ghannam DE, Rodriguez GH, Raad II, Safdar A. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis 28(3):253-9. e-Pub 2008. PMID: 18752007.
246. Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21(4):385-92, 2008. e-Pub 2008. PMID: 18594291.
247. Lamaris GA, Lewis RE, Chamilos G, May GS, Safdar A, Walsh TJ, Raad II, Kontoyiannis DP. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 198(2):186-92, 2008. e-Pub 2008. PMID: 18500936.
248. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112(11):2493-9, 2008. e-Pub 2008. PMID: 18412153.
249. Lamaris GA, Esmaeli B, Chamilos G, Desai A, Chemaly RF, Raad II, Safdar A, Lewis RE, Kontoyiannis DP. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 27(5):343-7, 2008. e-Pub 2008. PMID: 18183439.
250. Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer 112(6):1282-7, 2008. e-Pub 2008. PMID: 18224662.
251. Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22(3):496-503, 2008. e-Pub 2008. PMID: 18094720.
252. Youssef S, Hachem R, Chemaly RF, Adachi J, Ying J, Rolston K, Raad I. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother 61(2):421-4, 2008. e-Pub 2008. PMID: 18174198.
253. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica 93(1):157-8, 2008. e-Pub 2008. PMID: 18166808.
254. Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL, Shpall EJ, Rolston KV, Raad II, Chan KW, Champlin RE. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore) 86(6):324-33, 2007. e-Pub 2007. PMID: 18004177.
255. Mulanovich V, Lewis RE, Raad II, Kontoyiannis DP. Random plasma concentrations of voriconazole decline over time. J Infect 55(5):e129-30, 2007. e-Pub 2007. PMID: 17804077.
256. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7(10):645-57, 2007. e-Pub 2007. PMID: 17897607.
257. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT, Han X. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110(6):1303-6, 2007. e-Pub 2007. PMID: 17614303.
258. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF. Characteristics and Outcome of Respiratory syncytial virus infection in patients with leukemia. Haematologica 92(9):1216-23, 2007. e-Pub 2007. PMID: 17666367.
259. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 28(9):1054-9, 2007. e-Pub 2007. PMID: 17932826.
260. Keutgen X, Hachem R, Jiang Y, Pham-Williams T, Tarrand J, Raad I. A comparison of galactomannan-ELISA and a newly developed galactomannan-LATEX test in the serologic diagnosis of invasive aspergillosis in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 26(9):655-8, 2007. e-Pub 2007. PMID: 17623114.
261. Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther 29(9):1980-6, 2007. e-Pub 2007. PMID: 18035197.
262. Shukrallah B, Hanna H, Hachem R, Ghannam D, Chatzinikolaou I, Raad I. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis 58(4):453-7, 2007. e-Pub 2007. PMID: 17509805.
263. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 26(8):549-56, 2007. e-Pub 2007. PMID: 17582536.
264. Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 109(12):2615-22, 2007. e-Pub 2007. PMID: 17487860.
265. Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother 51(6):1905-11, 2007. e-Pub 2007. PMID: 17387153.
266. Ghanem G, Adachi J, Han XY, Raad I. Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol 28(5):599-601, 2007. e-Pub 2007. PMID: 17464923.
267. Bahna P, Dvorak T, Hanna H, Yasko AW, Hachem R, Raad I. Orthopaedic metal devices coated with a novel antiseptic dye for the prevention of bacterial infections. Int J Antimicrob Agents 29(5):593-6, 2007. e-Pub 2007. PMID: 17317111.
268. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51(5):1656-60, 2007. e-Pub 2007. PMID: 17353249.
269. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 44(7):964-7, 2007. e-Pub 2007. PMID: 17342649.
270. Bayet C, Fazio C, Darbour N, Berger O, Raad I, Chaboud A, Dumontet C, Guilet D. Modulation of P-glycoprotein activity by acridones and coumarins from Citrus sinensis. Phytother Res 21(4):386-90, 2007. e-Pub 2007. PMID: 17236173.
271. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine (Baltimore) 86(2):69-77, 2007. e-Pub 2007. PMID: 17435587.
272. Safdar A, Rodriguez G, Rolston KV, O'Brien S, Khouri IF, Shpall EJ, Keating MJ, Kantarjian HM, Champlin RE, Raad II, Kontoyiannis DP. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant 39:157-64, 2007. e-Pub 2007. PMID: 17245424.
273. Aboufaycal H, Sader HS, Rolston K, Deshpande LM, Toleman M, Bodey G, Raad I, Jones RN. blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J Clin Microbiol 45(2):614-5, 2007. e-Pub 2007. PMID: 17151207.
274. Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 44(1):2-12, 2007. e-Pub 2007. PMID: 17143808.
275. Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) 86(1):54-60, 2007. e-Pub 2007. PMID: 17220756.
276. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51(1):78-83, 2007. e-Pub 2007. PMID: 17074799.
277. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis 26:13-20, 2007. e-Pub 2007. PMID: 17200840.
278. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 28(9):1054-1059, 2007. e-Pub 2007.
279. Shukrallah B, Hanna H, Hachem R, Ghannam D, Chatzinikolaou, Raad I. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis 58(4):453-457, 2007. e-Pub 2007.
280. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention and management. Lancet Infect Dis 7:645-657, 2007. e-Pub 2007.
281. Keutgen X, Hachem R, Jiang Y, Pham-Williams T, Tarrand J, Raad I. A comparison of galactomannan-ELISA and a newly developed galactomannan-LATEX test in the serologic diagnosis of invasive aspergillosis in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 26(9):655-658, 2007. e-Pub 2007.
282. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 44:964-967, 2007. e-Pub 2007.
283. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine 86(2):69-77, 2007. e-Pub 2007.
284. Raad I, Hanna H, Jiang Y, Dvorak T, Retizel R, Chaiban G, Sherertz R, Hachem R. Comparative activity of daptomycin, linezolid and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51(5):1656-1660, 2007. e-Pub 2007.
285. Ghanem G, Adachi J, X-Y H, Raad I. Central venous catheter-related streptomyces septic thrombosis. Infect Control Hosp Epidemiol 28(5):599-601, 2007. e-Pub 2007.
286. Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 109(12):2615-2622, 2007. e-Pub 2007.
287. Lee LD, Berkheiser M, Jiang Y, Hackett B, Hachem RY, Chemaly RF, Raad II. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol 28(9)(9):1066-1070, 2007. e-Pub 2007. PMID: 17932828.
288. Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II. Colistin is effective in the treatment of multidrug-resistant Pseudomonas aeruginosa infections in cancer patients. Antimicrob Agents Chemother 51(6):1905-1911, 2007. e-Pub 2007.
289. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 26(8):4390556, 2007. e-Pub 2007.
290. Safdar A, Rodriguez GH, De Lima MJ, Petropulos D, Chemaly RF, Worth LL, Shpall EJ, Rolston KVI, Raad II, Chan KW, Champlin RE. Infections in 100 cord blood transplantations. Spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine 86(6):324-333, 2007. e-Pub 2007.
291. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 43:1580-4, 2006. e-Pub 2006. PMID: 17109292.
292. Koubeissi A, Raad I, Ettouati L, Guilet D, Dumontet C, Paris J. Inhibition of P-glycoprotein-mediated multidrug efflux by aminomethylene and ketomethylene analogs of reversins. Bioorg Med Chem Lett 16(21):5700-3, 2006. e-Pub 2006. PMID: 16950619.
293. Safdar A, Rodriguez MA, Fayad LE, Rodriguez GH, Pro B, Wang M, Romaguera JE, Goy AH, Hagemeister FB, McLaughlin P, Bodey GP, Kwak LW, Raad II, Couch RB. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis 194:1394-7, 2006. e-Pub 2006. PMID: 17054068.
294. Raad I, Terreux R, Richomme P, Matera EL, Dumontet C, Raynaud J, Guilet D. Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein. Bioorg Med Chem 14(20):6979-87, 2006. e-Pub 2006. PMID: 16824763.
295. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534-6, 2006. e-Pub 2006. PMID: 17015161.
296. Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, Raad I. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother 50(10):3283-8, 2006. e-Pub 2006. PMID: 17005806.
297. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85:278-87, 2006. e-Pub 2006. PMID: 16974212.
298. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91(7):986-9, 2006. e-Pub 2006. PMID: 16757415.
299. Kumashi PR, Safdar A, Chamilos G, Chemaly RF, Raad II, Kontoyiannis DP. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect 12:621-6, 2006. e-Pub 2006. PMID: 16774557.
300. Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 106(12):2664-71, 2006. e-Pub 2006. PMID: 16691620.
301. Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, Rolston KV, Raad II, Kontoyiannis DP. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 25(6):382-8, 2006. e-Pub 2006. PMID: 16767486.
302. Bahna P, Hanna HA, Dvorak T, Vaporciyan A, Chambers M, Raad I. Antiseptic effect of a novel alcohol-free mouthwash: A convenient prophylactic alternative for high-risk patients. Oral Oncol 29(5):593-596, 2006. e-Pub 2006. PMID: 16798063.
303. Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 42(12):1726-34, 2006. e-Pub 2006. PMID: 16705579.
304. Hachem R, Bahna P, Hanna H, Stephens LC, Raad I. EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model. Antimicrob Agents Chemother 50(5):1823-7, 2006. e-Pub 2006. PMID: 16641455.
305. Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J, Rolston K, Safdar A, Raad I. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106(9):1967-73, 2006. e-Pub 2006. PMID: 16565968.
306. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 42(10):1398-403, 2006. e-Pub 2006. PMID: 16619151.
307. Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Int J Infect Dis 10(3):223-30, 2006. e-Pub 2006. PMID: 16439177.
308. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50(5):1865-8, 2006. e-Pub 2006. PMID: 16641463.
309. Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I. Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44(5):1834-5, 2006. e-Pub 2006. PMID: 16672415.
310. Hachem R, Sumoza D, Hanna H, Girgawy E, Munsell M, Raad I. Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised?. Cancer 106(7):1581-6, 2006. e-Pub 2006. PMID: 16475153.
311. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6(5):393-8, 2006. e-Pub 2006. PMID: 16640816.
312. Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh E, Raad II, Safdar A. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore) 85(2):86-94, 2006. e-Pub 2006. PMID: 16609347.
313. Ullmann AJ, Cornely OA, Burchardt A, Hachem R, Kontoyiannis DP, Töpelt K, Courtney R, Wexler D, Krishna G, Martinho M, Corcoran G, Raad I. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 50(2):658-66, 2006. e-Pub 2006. PMID: 16436724.
314. Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics?. Infect Control Hosp Epidemiol 27(2):195-7, 2006. e-Pub 2006. PMID: 16465639.
315. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 50(1):126-33, 2006. e-Pub 2006. PMID: 16377677.
316. Lionakis MS, Chamilos G, Lewis RE, Wiederhold NP, Raad II, Samonis G, Kontoyiannis DP. Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob Agents Chemother 50(1):294-7, 2006. e-Pub 2006. PMID: 16377700.
317. Mattiuzzi GN, Alvarado G, Giles FJ, Ostrosky-Zeichner L, Cortes J, O'Brien S, Verstovsek S, Faderl S, Zhou X, Raad II, Bekele BN, Leitz GJ, Lopez-Roman I, Estey EH. Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies. Antimicrob Agents Chemother 50(1):143-7, 2006. e-Pub 2006. PMID: 16377679.
318. Rolston KVI, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH. The spectrum of gram-positive bloodstream infection in patients with hematologic malignancies, and the in-vitro activity of various quinolones against gram-positive bacteria isolated from cancer patients. In press. Int J Infect Dis 10:223-230, 2006. e-Pub 2006.
319. Raad II, Hanna HA, Boktour M, Chaiban G, Hachem RY, Dvorak T, Lewis R, Murray BE. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother 49(12):5046-50, 2005. e-Pub 2005. PMID: 16304171.
320. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5(12):775-85, 2005. e-Pub 2005. PMID: 16310149.
321. Aisenberg GM, Jacobson K, Chemaly RF, Rolston KV, Raad II, Safdar A. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005). Cancer 104(12):2882-7, 2005. e-Pub 2005. PMID: 16245341.
322. Hanna R, Raad II. Diagnosis of catheter-related bloodstream infection. Curr Infect Dis Rep 7:413-9, 2005. e-Pub 2005. PMID: 16225778.
323. Healy M, Reece K, Walton D, Huong J, Frye S, Raad II, Kontoyiannis DP. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 43(10):5278-80, 2005. e-Pub 2005. PMID: 16207996.
324. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41(15):2268-79, 2005. e-Pub 2005. PMID: 16143517.
325. Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 84(5):303-12, 2005. e-Pub 2005. PMID: 16148730.
326. Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104(6):1213-20, 2005. e-Pub 2005. PMID: 16078263.
327. Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 242(2):193-200, 2005. e-Pub 2005. PMID: 16041209.
328. Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, Dvorak T, Hogan H, Hachem R, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104(1):205-12, 2005. e-Pub 2005. PMID: 15880433.
329. Raad II, Hanna HA, Boktour M, Jabbour N, Hachem RY, Darouiche RO. Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 26(7):658-61, 2005. e-Pub 2005. PMID: 16092749.
330. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26(6):520-4, 2005. e-Pub 2005. PMID: 16018426.
331. Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103(11):2334-7, 2005. e-Pub 2005. PMID: 15844093.
332. Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 55(5):792-5, 2005. e-Pub 2005. PMID: 15814598.
333. Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52(1):15-20, 2005. e-Pub 2005. PMID: 15878437.
334. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191(8):1350-60, 2005. e-Pub 2005. PMID: 15776383.
335. Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad II. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis 51(3):215-8, 2005. e-Pub 2005. PMID: 15766609.
336. Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II, Champlin RE. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 103(4):731-9, 2005. e-Pub 2005. PMID: 15641032.
337. Raad I, Darouiche R, Vazquez J, Lentnek A, Hachem R, Hanna H, Goldstein B, Henkel T, Seltzer E. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 40(3):374-80, 2005. e-Pub 2005. PMID: 15668859.
338. Torres HA, Prieto VG, Raad II, Kontoyiannis DP. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans. Mycoses 48(1):21-4, 2005. e-Pub 2005. PMID: 15679661.
339. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two-decade experience in a tertiary care cancer center. Eur J Cancer 41(15):2268-2279, 2005. e-Pub 2005.
340. Chaiban G, Hanna H, Dvorak T, Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J Antimicrob Chemother 55(1):51-6, 2005. e-Pub 2005. PMID: 15574478.
341. Raad I Darouiche R. Management of Catheter Related Candidemia. Reply to Nucci and Anaissie. Clin Infect Dis 40(7):1064-1067, 2005. e-Pub 2005.
342. Raad II, Hanna HA, Boktour M, Chaiban G, Hachem RY, Dvorak T, Lewis R, Murray BE. Vancomycin Resistant Enterococcus faecum: Catheter Colonization, Esp Gene and Decreased Susceptibility to Antibiotics in Biofilm. Antimicrobial Agents in Chemotherapy 49(12):5046-5050, 2005. e-Pub 2005.
343. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39(11):1563-71, 2004. e-Pub 2004. PMID: 15578352.
344. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad II. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 101(12):2859-65, 2004. e-Pub 2004. PMID: 15529309.
345. Lee SA, Raad II, Adachi JA, Han XY. Catheter-related bloodstream infection caused by Mycobacterium brumae. J Clin Microbiol 42(11):5429-31, 2004. e-Pub 2004. PMID: 15528764.
346. Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer 101(10):2300-2, 2004. e-Pub 2004. PMID: 15452832.
347. Chatzinikolaou I, Hanna H, Hachem R, Alakech B, Tarrand J, Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 50(3):167-72, 2004. e-Pub 2004. PMID: 15541601.
348. Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101(7):1594-600, 2004. e-Pub 2004. PMID: 15378491.
349. Boktour MR, Kontoyiannis DP, Hanna HA, Hachem RY, Girgawy E, Bodey GP, Raad II. Multiple-species candidemia in patients with cancer. Cancer 101(8):1860-5, 2004. e-Pub 2004. PMID: 15386338.
350. Radhakrishnan R, Donato ML, Prieto VG, Mays SR, Raad II, Kuerer HM. Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. J Surg Oncol 88(1):21-26, 2004. e-Pub 2004. PMID: 15384060.
351. Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 10(10):922-5, 2004. e-Pub 2004. PMID: 15373888.
352. Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, Rice LB. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 48(9):3583-5, 2004. e-Pub 2004. PMID: 15328133.
353. Hanna H, Afif C, Alakech B, Boktour M, Tarrand J, Hachem R, Raad I. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 25(8):646-9, 2004. e-Pub 2004. PMID: 15357155.
354. De La Rosa GR, Jacobson KL, Rolston KV, Raad II, Kontoyiannis DP, Safdar A. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000. Clin Microbiol Infect 10(8):749-52, 2004. e-Pub 2004. PMID: 15301678.
355. Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22(15):3163-71, 2004. e-Pub 2004. PMID: 15284269.
356. Raad I, Hachem R, Hanna H. Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction. J Antimicrob Chemother 53(6):1105-8, 2004. e-Pub 2004. PMID: 15128724.
357. Hachem R, Graviss L, Hanna H, Arbuckle R, Dvorak T, Hackett B, Gonzalez V, Perego C, Tarrand J, Raad I. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 25(5):391-4, 2004. e-Pub 2004. PMID: 15188844.
358. Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother 53(4):646-9, 2004. e-Pub 2004. PMID: 14998986.
359. Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GP. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38(8):1119-27, 2004. e-Pub 2004. PMID: 15095217.
360. Mattiuzzi GN, Kantarjian H, O'Brien S, Kontoyiannis DP, Giles F, Zhou X, Lim J, Bekele BN, Faderl S, Cortes J, Pierce S, Leitz GJ, Raad I, Estey E. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer 100(3):568-73, 2004. e-Pub 2004. PMID: 14745874.
361. Mattiuzzi GN, Kantarjian H, Faderl S, Lim J, Kontoyiannis D, Thomas D, Wierda W, Raad I, Garcia-Manero G, Zhou X, Ferrajoli A, Bekele N, Estey E. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer 100(3):581-9, 2004. e-Pub 2004. PMID: 14745876.
362. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140(1):18-25, 2004. e-Pub 2004. PMID: 14706968.
363. Kontoyiannis DP, Bodey GP, Hanna H, Hachem R, Boktour M, Girgaway E, Mardani M, Raad II. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma 45(1):139-41, 2004. e-Pub 2004. PMID: 15061210.
364. Vora YA, Raad II, McCutcheon IE. Intramedullary abscess from group F Streptococcus. Surg Infect (Larchmt) 5(2):200-4, 2004. e-Pub 2004. PMID: 15353118.
365. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36(8):564-9, 2004. e-Pub 2004. PMID: 15370667.
366. Kontoyiannis DP, Hanna H, Hachem R, Boktour M, Girgawy E, Mardani M, Bodey G, Raad I. Risk factors of poor outcome of fusariosis in a tertiary care cancer center. Leuk Lymphoma 45:141-143, 2004. e-Pub 2004.
367. Safdar A, Chemaly RF, Perego CA, Gonzalez VR, Rolston KV, Raad II, Tarrand JJ, Callender DL. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer 98(12):2738-9, 2003. e-Pub 2003. PMID: 14669300.
368. Chatzinikolaou I, Hanna H, Graviss L, Chaiban G, Perego C, Arbuckle R, Champlin R, Darouiche R, Samonis G, Raad I. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 24(12):961-3, 2003. e-Pub 2003. PMID: 14700414.
369. Torres HA, Raad II, Kontoyiannis DP. Infections caused by Fusarium species. J Chemother 15 Suppl 2:28-35, 2003. e-Pub 2003. PMID: 14708964.
370. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47(11):3580-5, 2003. e-Pub 2003. PMID: 14576121.
371. Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad I. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 115(5):352-7, 2003. e-Pub 2003. PMID: 14553869.
372. Kontoyiannis DP, Lewis RE, Lionakis MS, Albert ND, May GS, Raad II. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Diagn Microbiol Infect Dis 47(2):415-9, 2003. e-Pub 2003. PMID: 14522515.
373. Hong DS, Jacobson KL, Raad II, de Lima M, Anderlini P, Fuller GN, Ippoliti C, Cool RM, Leeds NE, Narvios A, Han XY, Padula A, Champlin RE, Hosing C. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis 37(8):1044-9, 2003. e-Pub 2003. PMID: 14523768.
374. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 82(5):309-21, 2003. e-Pub 2003. PMID: 14530780.
375. Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer 98(5):1039-47, 2003. e-Pub 2003. PMID: 12942573.
376. Hanna HA, Raad II, Hackett B, Wallace SK, Price KJ, Coyle DE, Parmley CL. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 124(3):1030-8, 2003. e-Pub 2003. PMID: 12970034.
377. Hachem RY, Wright KC, Zermeno A, Bodey GP, Raad II. Evaluation of the silver iontophoretic catheter in an animal model. Biomaterials 24(20):3619-22, 2003. e-Pub 2003. PMID: 12809792.
378. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 98(1):86-93, 2003. e-Pub 2003. PMID: 12833460.
379. Hachem RY, Hicks K, Huen A, Raad I. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis 37(1):e8-11, 2003. e-Pub 2003. PMID: 12830431.
380. Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 98(2):292-9, 2003. e-Pub 2003. PMID: 12872348.
381. Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 46(1):25-8, 2003. e-Pub 2003. PMID: 12742315.
382. Bodey GP, Rolston KV, Raad II. Ciprofloxacin versus tobramycin for neutropenic fevers. Ann Intern Med 138(5):435; author reply 436, 2003. e-Pub 2003. PMID: 12614101.
383. Mattiuzzi GN, Cortes JE, Talpaz M, Reuben J, Rios MB, Shan J, Kontoyiannis D, Giles FJ, Raad I, Verstovsek S, Ferrajoli A, Kantarjian HM. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res 9(3):976-80, 2003. e-Pub 2003. PMID: 12631595.
384. Esmaeli B, Holz ER, Ahmadi MA, Krathen RA, Raad II. Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection. Retina 23(1):118-9, 2003. e-Pub 2003. PMID: 12652247.
385. Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Cancer 97(2):450-6, 2003. e-Pub 2003. PMID: 12518369.
386. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R, Hachem R, Raad I. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36(1):116-9, 2003. e-Pub 2003. PMID: 12491212.
387. Hadi U, Bitar M, Hachem R, Saade R, Husni R, Raad I. Fungal sinusitis in the immunocompetent patient: risk factors and surgical management. Surg Infect (Larchmt) 4(2):199-204, 2003. e-Pub 2003. PMID: 12906720.
388. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine 115(5):352-357, 2003. e-Pub 2003.
389. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23(12):759-69, 2002. e-Pub 2002. PMID: 12517020.
390. O'Grady N P, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30(8):476-89, 2002. e-Pub 2002. PMID: 12461511.
391. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 110(5):e51, 2002. e-Pub 2002. PMID: 12415057.
392. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46(11):3499-505, 2002. e-Pub 2002. PMID: 12384356.
393. Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, Raad I. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 47(5):659-66, 2002. e-Pub 2002. PMID: 12399756.
394. Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, Bodey G, Mardani M, Hachem R, Kontoyiannis D, Whimbey E, Rolston K. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 23(9):532-7, 2002. e-Pub 2002. PMID: 12269452.
395. Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KV, Kontoyiannis DP. Nocardiosis in cancer patients. Medicine (Baltimore) 81(5):388-97, 2002. e-Pub 2002. PMID: 12352633.
396. Kontoyiannis DP, Reddy BT, Hanna H, Bodey GP, Tarrand J, Raad II. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol 23(9):542-5, 2002. e-Pub 2002. PMID: 12269454.
397. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51(RR-10):1-29, 2002. e-Pub 2002. PMID: 12233868.
398. Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarr JJ, Raad II. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 51(1):52-8, 2002. e-Pub 2002. PMID: 12009821.
399. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 112(5):380-5, 2002. e-Pub 2002. PMID: 11904112.
400. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest 121(4):1171-6, 2002. e-Pub 2002. PMID: 11948049.
401. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162(8):871-8, 2002. e-Pub 2002. PMID: 11966337.
402. Lewis RE, Lo HJ, Raad II, Kontoyiannis DP. Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother 46(4):1153-5, 2002. e-Pub 2002. PMID: 11897612.
403. Raad I, Hanna H, Sumoza D, Albitar M. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer 94(4):1032-6, 2002. e-Pub 2002. PMID: 11920473.
404. Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad II. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 34(3):400-3, 2002. e-Pub 2002. PMID: 11774088.
405. Raad I, Hachem R, Tcholakian RK, Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46(2):327-32, 2002. e-Pub 2002. PMID: 11796338.
406. Darouiche RO, Mansouri MD, Raad II. Efficacy of antimicrobial-impregnated silicone sections from penile implants in preventing device colonization in an animal model. Urology 59(2):303-7, 2002. e-Pub 2002. PMID: 11834416.
407. Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 23(2):102-3, 2002. e-Pub 2002. PMID: 11893144.
408. Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 20(7-8):1105-13, 2002. e-Pub 2002. PMID: 12449743.
409. Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23(1):41-3, 2002. e-Pub 2002. PMID: 11868892.
410. Reddy BT, Torres HA, Raad II, Rolston KVI, Whimbey EE, Jacobson K, Tarrand J, Bodey GP, Kontoyiannis DP. Nocardiosis in patients with cancer. Medicine 81(5):388-397, 2002. e-Pub 2002.
411. Hachem R, Raad I. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 23(1):43-4, 2002. e-Pub 2002. PMID: 11868893.
412. Raad I, Hachem R, Hanna H, Girgawy E, Rolston K, Whimbey E, Husni R, Bodey G. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrob Agents Chemother 45(11):3202-4, 2001. e-Pub 2001. PMID: 11600379.
413. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33(10):1676-81, 2001. e-Pub 2001. PMID: 11568858.
414. Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant 28(3):271-5, 2001. e-Pub 2001. PMID: 11535995.
415. Raad II, Hanna HA, Darouiche RO. Diagnosis of catheter-related bloodstream infections: is it necessary to culture the subcutaneous catheter segment?. Eur J Clin Microbiol Infect Dis 20(8):566-8, 2001. e-Pub 2001. PMID: 11681436.
416. Tcholakian RK, Raad II. Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents. Antimicrob Agents Chemother 45(7):1990-3, 2001. e-Pub 2001. PMID: 11408213.
417. Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 20(6):432-4, 2001. e-Pub 2001. PMID: 11476449.
418. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32(9):1249-72, 2001. e-Pub 2001. PMID: 11303260.
419. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 24(3):180-205, 2001. e-Pub 2001. PMID: 11530364.
420. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 22(4):222-42, 2001. e-Pub 2001. PMID: 11379714.
421. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 22(4):217-9, 2001. e-Pub 2001. PMID: 11379712.
422. Konoplev S, Champlin RE, Giralt S, Ueno NT, Khouri I, Raad I, Rolston K, Jacobson K, Tarrand J, Luna M, Nguyen Q, Whimbey E. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 27(8):877-81, 2001. e-Pub 2001. PMID: 11477447.
423. Raad I, Hachem R, Hanna H, Abi-Said D, Bivins C, Walsh G, Thornby J, Whimbey E, Huaringa A, Sukumaran A. Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. Ann Surg Oncol 8(2):179-86, 2001. e-Pub 2001. PMID: 11258785.
424. La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Elting L, Whimbey E. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 32(6):871-6, 2001. e-Pub 2001. PMID: 11247710.
425. Kontoyiannis DP, Andersson BS, Lewis RE, Raad II. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Clin Infect Dis 32(5):E94-6, 2001. e-Pub 2001. PMID: 11229866.
426. Hanna HA Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 22(3):165-6, 2001. e-Pub 2001. PMID: 11310696.
427. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, Richardson D, Umphrey JL, Whimbey E, Mansour G. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?. Infect Control Hosp Epidemiol 22(3):136-9, 2001. e-Pub 2001. PMID: 11310690.
428. Fleming RV, Kantarjian HM, Husni R, Rolston K, Lim J, Raad I, Pierce S, Cortes J, Estey E. Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia. Leuk Lymphoma 40(5-6):511-20, 2001. e-Pub 2001. PMID: 11426524.
429. Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 32(4):539-45, 2001. e-Pub 2001. PMID: 11181115.
430. Minari A, Hachem R, Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32(2):186-90, 2001. e-Pub 2001. PMID: 11170906.
431. Hanna H, Darouiche R, Raad I. New approaches for the prevention of intravascular catheter-related infection. Infections in Medicine 18:38-48, 2001. e-Pub 2001.
432. Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, Whimbey E, Hachem R, Raad I. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 160(17):2659-64, 2000. e-Pub 2000. PMID: 10999981.
433. Kontoyiannis DP, Jacobson KL, Whimbey EE, Rolston KV, Raad II. Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis 31(2):617-8, 2000. e-Pub 2000. PMID: 10987735.
434. Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 31(2):628-31, 2000. e-Pub 2000. PMID: 10987747.
435. Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad II. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis 31(1):188-9, 2000. e-Pub 2000. PMID: 10913421.
436. Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Tarrand J, Whimbey E. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30(6):965-9, 2000. e-Pub 2000. PMID: 10880318.
437. Mardani M, Hanna HA, Girgawy E, Raad I. Nosocomial Candida guilliermondii fungemia in cancer patients. Infect Control Hosp Epidemiol 21(5):336-7, 2000. e-Pub 2000. PMID: 10823569.
438. Huaringa AJ, Leyva FJ, Signes-Costa J, Morice RC, Raad I, Darwish AA, Champlin RE. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 25(9):975-9, 2000. e-Pub 2000. PMID: 10800066.
439. Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Mallik S, Whimbey E. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 25(7):751-5, 2000. e-Pub 2000. PMID: 10745261.
440. Raad I. Management of intravascular catheter-related infections. J Antimicrob Chemother 45(3):267-70, 2000. e-Pub 2000. PMID: 10702543.
441. Hanna H, Raad I, Gonzalez V, Umphrey J, Tarrand J, Neumann J, Champlin R. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 21(3):226-8, 2000. e-Pub 2000. PMID: 10738997.
442. Sumoza D, Raad I, Douglas E. Differentiating thoracic actinomycosis from lung cancer. Infections in Medicine 17(10):695-698, 2000. e-Pub 2000.
443. Raad I, Hanna H. Vascular catheter-related infections: current knowledge and practice. J Critical Illness 15(1):28-36, 2000. e-Pub 2000.
444. Darouiche RO, Smith JA, Jr, Hanna H, Dhabuwala CB, Steiner MS, Babaian RJ, Boone TB, Scardino PT, Thornby JI, Raad II. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54(6):976-81, 1999. e-Pub 1999. PMID: 10604693.
445. Raad I Hanna H. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections. Support Care Cancer 7(6):386-90, 1999. e-Pub 1999. PMID: 10541979.
446. Ghosh S, Champlin R, Couch R, Englund J, Raad I, Malik S, Luna M, Whimbey E. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 29(3):528-32, 1999. e-Pub 1999. PMID: 10530441.
447. Raad I, Bompart F, Hachem R. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis 18(3):199-202, 1999. e-Pub 1999. PMID: 10357054.
448. Nguyen Q, Champlin R, Giralt S, Rolston K, Raad I, Jacobson K, Ippoliti C, Hecht D, Tarrand J, Luna M, Whimbey E. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 28(3):618-23, 1999. e-Pub 1999. PMID: 10194088.
449. Nichols RL, Raad II. Management of bacterial complications in critically ill patients: surgical wound and catheter-related infections. Diagn Microbiol Infect Dis 33(2):121-30, 1999. e-Pub 1999. PMID: 10091035.
450. Abi-Said D, Raad I, Umphrey J, Gonzalez V, Richardson D, Marts K, Hohn D. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 20(2):101-5, 1999. e-Pub 1999. PMID: 10064212.
451. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340(1):1-8, 1999. e-Pub 1999. PMID: 9878638.
452. Elting LS, Rubenstein EB, Kurtin D, Rolston KV, Fangtang J, Martin CG, Raad II, Whimbey EE, Manzullo E, Bodey GP. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer 83(12):2597-607, 1998. e-Pub 1998. PMID: 9874468.
453. Darouiche RO, Meade R, Mansouri M, Raad II. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. J Heart Valve Dis 7(6):639-46, 1998. e-Pub 1998. PMID: 9870198.
454. Jacobson K, Garcia R, Libshitz H, Whimbey E, Rolston K, Abi-Said D, Raad I. Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients. Eur J Clin Microbiol Infect Dis 17(9):615-21, 1998. e-Pub 1998. PMID: 9832262.
455. Raad I, Abi-Said D, Carrasco CH, Umphrey J, Hill LA. The risk of infection associated with intra-arterial catheters for cancer chemotherapy. Infect Control Hosp Epidemiol 19(9):640-2, 1998. e-Pub 1998. PMID: 9778160.
456. Raad II, Abi-Said D, Rolston KV, Karl CL, Bodey GP. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?. Cancer 82(12):2449-58, 1998. e-Pub 1998. PMID: 9635539.
457. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26(5):1182-7, 1998. e-Pub 1998. PMID: 9597250.
458. Raad I. Intravascular-catheter-related infections. Lancet 351(9106):893-8, 1998. e-Pub 1998. PMID: 9525387.
459. Raad II, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M, Morck D. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 26(2):219-24, 1998. e-Pub 1998. PMID: 9468157.
460. Raad II, Hachem RY, Abi-Said D, Rolston KV, Whimbey E, Buzaid AC, Legha S. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer 82(2):403-11, 1998. e-Pub 1998. PMID: 9445199.
461. Hachem RY, Raad I. Clinical presentation and management of multi-resistant Staphylococcus epidermidis (MRSE) bloodstream infections. IN: Resistant nosocomial pathogens: recent advances in the management of MRSA, MRSE, and VRE. Antibiotics for Clinicians 2(Suppl 1):21-24, 1998. e-Pub 1998.
462. Escalante C, Raad I, Gokaslan Z, Fuller G, Garcia R. Cerebellar mass: is it malignancy or histoplasmosis?. Primary Care & Cancer 18(10):35-37, 40, 1998. e-Pub 1998.
463. Darouiche RO, Safar H, Raad II. In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface. J Infect Dis 176(4):1109-12, 1997. e-Pub 1997. PMID: 9333179.
464. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127(4):267-74, 1997. e-Pub 1997. PMID: 9265425.
465. Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25(1):149-51, 1997. e-Pub 1997. PMID: 9243049.
466. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24(6):1122-8, 1997. e-Pub 1997. PMID: 9195068.
467. Garcia R, Raad I, Abi-Said D, Bodey G, Champlin R, Tarrand J, Hill LA, Umphrey J, Neumann J, Englund J, Whimbey E. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 18(6):412-6, 1997. e-Pub 1997. PMID: 9181397.
468. Darouiche RO, Hampel OZ, Boone TB, Raad II. Antimicrobial activity and durability of a novel antimicrobial-impregnated bladder catheter. Int J Antimicrob Agents 8(4):243-7, 1997. e-Pub 1997. PMID: 18611809.
469. Raad IL. Vascular catheters impregnated with antimicrobial agents: present knowledge and future direction. Infect Control Hosp Epidemiol 18(4):227-9, 1997. e-Pub 1997. PMID: 9131363.
470. Darouiche RO, Raad II. Prevention of catheter-related infections: the skin. Nutrition 13(4 Suppl):26S-29S, 1997. e-Pub 1997. PMID: 9178307.
471. Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 35(3):641-6, 1997. e-Pub 1997. PMID: 9041404.
472. Rolston KV, Rodriguez S, Dholakia N, Whimbey E, Raad I. Pulmonary infections mimicking cancer: a retrospective, three-year review. Support Care Cancer 5(2):90-3, 1997. e-Pub 1997. PMID: 9069606.
473. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 102(3A):48-52; discussion 53-4, 1997. e-Pub 1997. PMID: 10868143.
474. Darouiche RO, Hampel OZ, Boone TB, Raad II. Antimicrobial activity and durability of a novel antimicrobial-impregnated bladder catheter. International Journal Antimicrobial Agents 8:243-247, 1997. e-Pub 1997.
475. Husni R, Raad I. Treatment and prevention of vancomycin-resistant Enterococcus. Current Opinion in Infectious Diseases 10(6):431-434, 1997. e-Pub 1997.
476. Garcia R Raad I. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections. Eur J Clin Microbiol Infect Dis 15(12):933-6, 1996. e-Pub 1996. PMID: 9031876.
477. Sherertz RJ, Heard SO, Raad II, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother 40(9):1995-7, 1996. e-Pub 1996. PMID: 8878569.
478. Bodey G, Abi-Said D, Rolston K, Raad I, Whimbey E. Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients. Eur J Clin Microbiol Infect Dis 15(8):625-34, 1996. e-Pub 1996. PMID: 8894569.
479. Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 101(2):170-6, 1996. e-Pub 1996. PMID: 8757357.
480. Hachem R, Raad I, Rolston KV, Whimbey E, Katz R, Tarrand J, Libshitz H. Cutaneous and pulmonary infections caused by Mycobacterium vaccae. Clin Infect Dis 23(1):173-5, 1996. e-Pub 1996. PMID: 8816149.
481. Raad I, Hachem R, Zermeno A, Dumo M, Bodey GP. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 17(11):1055-9, 1996. e-Pub 1996. PMID: 8718964.
482. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N, Yousuf H, Tarrand JJ, Bodey GP. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22(5):778-82, 1996. e-Pub 1996. PMID: 8722930.
483. Raad II, Whimbey EE, Rolston KV, Abi-Said D, Hachem RY, Pandya RG, Ghaddar HM, Karl CL, Bodey GP. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer 77(7):1386-94, 1996. e-Pub 1996. PMID: 8608520.
484. Raad I, Hachem R, Leeds N, Sawaya R, Salem Z, Atweh S. Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain. Clin Infect Dis 22(3):572-4, 1996. e-Pub 1996. PMID: 8852983.
485. Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 173(2):495-8, 1996. e-Pub 1996. PMID: 8568321.
486. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173(2):418-24, 1996. e-Pub 1996. PMID: 8568304.
487. Raad I Darouiche R. Catheter-related septicemia: Risk reduction. Infections in Medicine 13(9):807-823, 1996. e-Pub 1996.
488. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39(11):2397-400, 1995. e-Pub 1995. PMID: 8585715.
489. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents 6(1):31-6, 1995. e-Pub 1995. PMID: 18611682.
490. Whimbey E, Couch RB, Englund JA, Andreeff M, Goodrich JM, Raad II, Lewis V, Mirza N, Luna MA, Baxter B, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 21(2):376-9, 1995. e-Pub 1995. PMID: 8562747.
491. Raad I, Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 20(3):709-11, 1995. e-Pub 1995. PMID: 7756502.
492. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 20(3):593-7, 1995. e-Pub 1995. PMID: 7756481.
493. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 14(2):134-7, 1995. e-Pub 1995. PMID: 7758480.
494. Raad II, Fraschini G. Intravascular device-related infections in cancer patients. Cancer Treat Res 79:211-31, 1995. e-Pub 1995. PMID: 8746656.
495. Rubenstein EB, Fender A, Rolston KVI, Elting LS, Prasco P, Palmer J, Raad I, Pollock RE, Frisbee-Hume S, Laurence D, Hohn D. Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 13(6):1513-1519, 1995. e-Pub 1995.
496. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Internat J Antimicr Agents 6:31-36, 1995. e-Pub 1995.
497. Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 170(3):720-3, 1994. e-Pub 1994. PMID: 7915751.
498. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. Jama 271(13):1014-6, 1994. e-Pub 1994. PMID: 8139059.
499. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15(4 Pt 1):231-8, 1994. e-Pub 1994. PMID: 8207189.
500. Clayman GL, Raad II, Hankins PD, Weber RS. Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 15(6):526-31, 1993. e-Pub 1993. PMID: 8253560.
501. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168(2):400-7, 1993. e-Pub 1993. PMID: 8335977.
502. Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodey GP. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 153(15):1791-6, 1993. e-Pub 1993. PMID: 8392831.
503. Raad I, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 23(1):17-26, 1993. e-Pub 1993. PMID: 8095944.
504. Weber RS, Hankins P, Rosenbaum B, Raad I. Nonwound infections following head and neck oncologic surgery. Laryngoscope 103(1 Pt 1):22-7, 1993. e-Pub 1993. PMID: 8421415.
505. Weber RS, Raad I, Frankenthaler R, Hankins P, Byers RM, Guillamondegui O, Wolf P, Smith T, Goepfert H. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 118(11):1159-63, 1992. e-Pub 1992. PMID: 1418893.
506. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 11(8):675-82, 1992. e-Pub 1992. PMID: 1425725.
507. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 15(2):197-208, 1992. e-Pub 1992. PMID: 1520756.
508. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 13(4):215-21, 1992. e-Pub 1992. PMID: 1593102.
509. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 14(1):75-82, 1992. e-Pub 1992. PMID: 1571466.
510. Raad II, Sabbagh MF, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 15(1):13-20, 1992. e-Pub 1992. PMID: 1730183.
511. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 13(6):1120-5, 1991. e-Pub 1991. PMID: 1775845.
512. Singh V, Raad I, Hamadeh R. AIDS and residency training. Ann Intern Med 114(7):605-6, 1991. e-Pub 1991. PMID: 2001096.
513. Singh VR, Raad I. Fatal Staphylococcus saprophyticus native valve endocarditis in an intravenous drug addict. J Infect Dis 162(3):783-4, 1990. e-Pub 1990. PMID: 2388008.
514. Raad I, Rand K, Gaskins D. Buffered charcoal-yeast extract medium for the isolation of brucellae. J Clin Microbiol 28(7):1671-2, 1990. e-Pub 1990. PMID: 2116452.
515. Raad II, Sabbagh MF, Caranasos GJ. Acute bacterial sialadenitis: a study of 29 cases and review. Rev Infect Dis 12(4):591-601, 1990. e-Pub 1990. PMID: 2385766.
516. Raad II, Sherertz RJ, Russell BA, Reuman PD. Uncontrolled nosocomial rotavirus transmission during a community outbreak. Am J Infect Control 18(1):24-8, 1990. e-Pub 1990. PMID: 2156470.
517. Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28(1):76-82, 1990. e-Pub 1990. PMID: 2405016.
518. Raad I, Cusick J, Sherertz RJ, Sabbagh M, Howell N. Annual tuberculin skin testing of employees at a university hospital: a cost-benefit analysis. Infect Control Hosp Epidemiol 10(10):465-9, 1989. e-Pub 1989. PMID: 2509550.
519. Raad I, Singh V, Quan TJ. Concurrent positive serology for ehrlichiosis and Lyme disease. J Infect Dis 160(4):727-8, 1989. e-Pub 1989. PMID: 2794568.
520. Raad II, Sherertz RJ, Rains CS, Cusick JL, Fauerbach LL, Reuman PD, Belcuore TR. The importance of nosocomial transmission of measles in the propagation of a community outbreak. Infect Control Hosp Epidemiol 10(4):161-6, 1989. e-Pub 1989. PMID: 2715628.
521. Raad II, Sherertz RJ, Loveless MO, Carillo C, O'Connor RP, Miller M, Mostow SR. Comparison of cefpimizole with cefotaxime and penicillin G for treatment of uncomplicated gonorrhea. Sex Transm Dis 15(2):73-7, 1988. e-Pub 1988. PMID: 3041630.
522. Rand KH, Raad I, el Koussi A, Houck HJ, Brey W, Rocca J, Loftsson T, Bodor N. Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model. J Virol Methods 18(4):257-69, 1987. e-Pub 1987. PMID: 2832432.
523. Rand KH, Bodor N, el Koussi AA, Raad I, Miyake A, Houck H, Gildersleeve N. Potential treatment of herpes simplex virus encephalitis by brain-specific delivery of trifluorothymidine using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. J Med Virol 20(1):1-8, 1986. e-Pub 1986. PMID: 3020165.
524. Uwaydah M, Vartivarian S, Shatila S, Raad I, Harakeh H, Nassar NT. Moxalactam in the treatment of typhoid fever. Antimicrob Agents Chemother 30(2):338-9, 1986. e-Pub 1986. PMID: 3532946.

Invited Articles

1. Hanna R, Raad I. Diagnosis of catheter-related bloodstream infection. Curr Infect Dis Rep 7(6):413-419, 2005. e-Pub 2005.
2. Raad I. The use of PCR and galactomannan assays for the diagnosis of invasive aspergillosis. [Perspectives]. MD Consult Infectious Disease, 2005. e-Pub 2005.
3. Raad I. The positive value of antibiotic-coated central lines. In press. Current Treatment Options in Infectious Diseases, 2005. e-Pub 2005.
4. Raad I. Patients with intravascular catheters and candidemia: Is catheter removal necessary? [Perspectives]. . MD Consult Infectious Disease. Available at: http://www.mdconsult.com, 2002. e-Pub 2002.
5. Chatzinikolaou I, Raad, II. Intravascular catheter-related infections: a preventable challenge in the critically ill. Semin Respir Infect 15(4):264-71, 2000. e-Pub 2000. PMID: 11220408.
6. Chatzinikolaou I Raad I. Central venous catheters coated with antimicrobial agents. Infections in Oncology 4(4):8-10, 2000. e-Pub 2000.
7. Raad I Hanna H. Inpatient monotherapy of febrile neutropenic patients: the role of imipenem. Infections in Oncology 3(2):2-4, 1999. e-Pub 1999.
8. Husni R Raad I. Vancomycin-resistant Enterococcus. Infections in Oncology 2(5):5-7, 1998. e-Pub 1998.
9. Raad II. Vascular catheters impregnated with antimicrobial agents: present knowledge and future direction [Editorial]. Infect Contr and Hosp Epidemiol 18:227-229, 1997. e-Pub 1997.
10. Raad I, Darouiche R. Prevention of infections associated with intravascular devices. Current Opinion in Critical Care 2:361-365, 1996. e-Pub 1996.
11. Raad I. Vascular catheter associated fungemia in cancer patients. Cliniguide to Fungal Infections 6(3):5-7, 1995. e-Pub 1995.
12. Raad II. The pathogenesis and prevention of central venous catheter-related infections. Middle East J Anesthesiol 12(4):381-403, 1994. e-Pub 1994. PMID: 8007893.
13. Raad I. Vascular catheter-related infections: Diagnosis and management. Today's Therapeutic Trends 9(4):27-41, 1992. e-Pub 1992.

Manuals, Teaching Aids, Other Teaching Publications

1. Raad I. Use of PCR in the diagnosis of aspergillosis, 2002.
2. Raad I. Patients with intravascular catheters and candidemia: s catheter removal necessary? , 2002.
3. Raad I. Vascular catheter-related infections, 1998.
4. Raad I. Infectious complications of venous access devices: Relevance of thrombosis mechanisms, 1992.
5. Fauerbach L, Raad I, Pickett D, Straub D. AIDS: The facts, 1988.

Editorials

1. Raad I, Bodey GP. Novel antimicrobial catheter lock solution: a new direction where chelators replace heparin. Crit Care Med 39(4):875-6, 2011.
2. Raad I. Commentary: Zero tolerance for catheter-related bloodstream infections: the unnegotiable objective. Infect Control Hosp Epidemiol 29(10):951-3, 2008.
3. Raad I. Gram-negative bacillary bacteremia and intravenous therapy practices. Infect Control Hosp Epidemiol 25:189-91, 2004. PMID: 15061407.

Abstracts

1. Hachem R, Datoguia T, Siddiqui B, Cruz AF, Mori N, Fakhreddine A, Lee DG, Gorak E, Somer R, Bhinder A, Shelanski S, Dragivich T, Bayle A, Chemaly R, Mulanovich V, Adachi J, Malek A, Slavin M, Jiang Y, Chaftari AM, Raad I. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
2. Gerges BZ, Rosenblatt R, TruongYL, Reitzel RA, Hachem R, Raad II. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
3. Torres HA, Angelidakis GA, Jiang Y, Economides M, Yibirin M, Orlowski R, Champlin R, Verstovsek S, Raad I. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
4. Dagher H, Hachem R, Chaftari AM, Jiang Y, Ali S, Deeba R, Shah S, Raad I. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
5. Chaftari P, Chaftari AM, Hachem R, Yeung, SJ, Dagher H, JiangY, Malek AE, Mulanovich VE, Raad I. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
6. Chaftari AM, Hachem R, Malek AE, Mulanovich V, Szvalb A, Jiang Y, Ali S, Deeba R, Chaftari P, Raad I. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
7. Malek AE, Chaftari P, Dagher HR, Hachem R, Chaftari AM, Viola GM, Raad II. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation. ID Week 2020 Virtual Conference, 2020. e-Pub 2020.
8. Malek AE, Nieto Y, Szvalb AD, Siddiqui S, Shafi MA, Hwang JP, Raad II, Torres HA. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
9. Viola GM, Rolston KVI, Butler C, Selber J, Reece G, Clemens M, Villa M, Ariza Heredia E, Raad I, Baumann D. Are current perioperative antimicrobial regimens adequate for the prevention of breast implant-based reconstructive surgeries?. 29th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Netherlands, April 13-16, 2019, 2019. e-Pub 2019.
10. Graviss L, Raad I, Chemaly R. Culture-documented invasive mold infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, TX pre and post hurricane Harvey. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
11. Reitzel R, Rosenblatt J, Hachem RY, A-M C, Wilson Dib R, Raad I. Repeated exposures to Minocycline/Rifampin and + Chlorhexidine combination used to coat catheters fails to induce antimicrobial resistance. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
12. Wilson Dib R, Fernandez-Cruz A, Jiang Y, Hachem RY, A-M C, Raad I. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
13. Wilson Dib R, A-M C, Hachem R, Jiang Y, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
14. Hachem R, Reitzel R, Vargas-Cruz N, Holland TL, Fowler Jr VG, Raad I. Whole Genome Sequencing Analysis of a Large Cohort of Staphylococcus epidermidis Blood Culture Positive Isolates from a Multicenter Clinical Trial. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
15. A-M C, Wilson Dib R, Kontoyiannis DP, Raad I. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution is highly effective in eradicating Candida auris biofilms. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
16. Rolston KVI, Gerges B, Raad I, Aitken SL, Reitzel R, Prince R. In vitro Activity of Cefiderocol and Comparator Agents against Gram-negative Isolates from Cancer Patients. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
17. Wurster S, Raman NM, Albert N, Raad I, Beyda N, Kontoyiannis DP. Drosophila melanogaster as a Facile Model for Large-Scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in Candida auris Candidiasis. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
18. Artau A, Taremi M, Foolad F, Berlin S, White C, Mulanovich V, Raad I, Adachi J. Safety, Efficacy and Clinical Impact of Penicillin Allergy Skin Testing in Immunocompromised Cancer Patients at a Comprehensive Cancer Center. ID Week 2018, Infectious Diseases Society of America, San Francisco, CA, 2018. e-Pub 2018.
19. Wilson Dib R, Chaftari AM, Hachem R, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis (ST): The Role of Anticoagulation Therapy. Division of Internal Medicine Research Retreat, 2018. e-Pub 2018.
20. Rosenblatt J, Reitzel R, Vargas-Cruz N, Hachem R, Chaftari AM, Wilson Dib R, Kontoyiannis D, Raad I. Candida auris Biofilm Eradication by Nitroglycerin-Citrate-Ethanol Catheter Lock Solution. Division of Internal Medicine Research Retreat, 2018. e-Pub 2018.
21. Hachem R, Reitzel R, Rosenblatt J, Vargas-Cruz N, Hill L, Moore LMeyer J, Gagea MRaad I. Porcine Wound Healing Model with a Novel Non-Antibiotic Wound Ointment. Division of Internal Medicine Research Retreat, 2018. e-Pub 2018.
22. Reitzel R, Chaftari AM, Wilson Dib R, Fieldman A, Numan L, Hachem R, Rosenblatt J, Raad I. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas MD Anderson Cancer Center: a 26,000 parenteral nutrition-day experience. Division of Internal Medicine Research Retreat, 2018. e-Pub 2018.
23. Wilson Dib R, Chaftari AM, Ghaly F, Jiang Y, Hachem R, Raad. Comparing diagnostic driven approaches to empiric therapy in the treatment of invasive aspergillosis in patients with hematologic malignancy. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
24. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Foley catheter with peri-urethral antimicrobial irrigation for the prevention of catheter associated urinary tract infections – assessment in an in vitro model. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
25. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Comparative efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in vitromodel of Catheter-Related Fungemia. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
26. Wilson Dib R, Numan Y, Li X, Kalia A, Raad I, MD, Shelburne S. Invasive Staphylococcus Epidermidis isolates are highly clonal and distinct from commensal strains: time for a new paradigm in infection control?. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
27. Chaftari AM, Raad I. Catheter lock with minocycline, EDTA and ethanol for salvaging of central venous catheters in the setting of catheter-related bloodstream infections. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
28. Chaftari AM, MD, Raad S, Hachem R, Shah P, Jiang J, Natividad E, Cleeland C, Rosenblatt J, Raad I. Unnecessary removal of central venous catheters in cancer patients with bloodstream infections: impact on symptom burden. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
29. Reitzel R, Chaftari AM, Feldman A, Numan L, Hachem R, Rosenblatt J, Raad. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas MD Anderson Cancer Center: a 26,000 parenteral nutrition-day experienceI. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
30. Holland TL, Boucher HW, Raad I, Anderson DJ, Cosgrove SE, Aycock S, MSN, Baddley JW, S-C C, Chu VH, Cook PP, Corey GR, Daly JS, Hachem RY, Chaftari AM, Horton JM, Jenkins TC, Gu J, Levine DP, Miro JM, Riska P, Rubin ZA, Rupp ME, Schrank J, Sims M, Wray D, Zervos MJ, Fowler V. Doing the same with less: A randomized, multinational, open-label, adjudicator-blinded trial of an algorithm vs. standard of care to determine treatment duration for Staphylococcal bacteremia. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
31. El Haddad H, Viola G, Jiang Y, Raad I, Rolston KV, Szvalb A. Percutaneous nephrostomy tube related-infections. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
32. Rosenblatt J, Reitzel, R, Viola, G, Vargas-Cruz, N, Selber, J, Raad, I. Sodium Mercaptoethane Sulfonate (MeSNA) reduces collagenolytic degradation and synergistically enhances antimicrobial activity against resistant organism in an antibiotic-loaded biopolymer film for prevention of surgical site infections. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, Houston, Texas, 2017. e-Pub 2017.
33. Rosenblatt, J, Reitzel, R, Hachem, R, Chaftari, A, Raad, I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, Houston, Texas, 2017. e-Pub 2017.
34. Hachem R, Retizel, R, Chaftari A, Rolston, K Raad I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparator Agents against Resistant Clinical Bacteria Isolates from cancer patients. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, Houston, Texas, 2017. e-Pub 2017.
35. Rosenblatt, J, Reitzel, R, Chaftari, A, Hachem, R, Raad, I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an extended panel of highly resistant Pathogens including Vancomycin intermediate Staphylococcus aureus (VISA) and Carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, Houston, Texas, 2017. e-Pub 2017.
36. Vargas-Cruz, N, Reitzel, R, Rosenblatt, J, Jamal, M, Szvalb, A, Chaftari AM, Hachem, R, Raad, I. Activity of Antimicrobial Percutaneous Nephrostomy Catheters for the prevention of Renal Infections: In vitro studies. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, Houston, Texas, 2017. e-Pub 2017.
37. A-M C, Hachem R, Raad S, Szvalb A, Taremi M, Granwehr B, Viola G, Sapna A, Assaf A, Numan Y, Shah P, Felix E, Natividad E, Jiang Y, Slack R, Reitzel, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Related Bloodstream Infections (CRBSI) in Cancer Patients. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
38. Numan Y, Shelburne S, Hachem R, Ghaoui S, A-M C, Raad I. Molecular Epidemiology Determinants of Invasive S. Epidermidis in Cancer Patients. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
39. Rolston KVI, Jamal M, Nesher L, Shelburne S, Raad I, Prince R. In-vitro activity of Ceftaroline and Comparator Agents against Bacterial Isolates from Cancer Patients. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
40. Rosenblatt J, Reitzel R, Hachem R, A-M C, Raad I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
41. Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, A-M C, Raad I. To Compare the Safety and Efficacy of Voriconazole versus Posaconazole in the Prevention of Invasive Fungal Infections in High Risk Patients with Hematologic Malignancies or Hematopoietic Stem Cell Transplant. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
42. Rosenblatt J, Reitzel R, Viola G, Selber J, Raad I. Prolonged Antimicrobial Durability of a Sodium Mercaptoethane Sulfonate (MeSNA) + Minocycline (M) + Rifampin (R) Combination in an In SituMelting, Bioabsorbable Wrap for Preventing Tissue Expander Infections Following Breast Reconstruction Surgeries. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
43. Rosenblatt J, Reitzel R, A-M C, Hachem R, Raad I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an Extended Panel of Highly Resistant Pathogens Including Vancomycin Intermediate Staphylococcus aureus (VISA) and Carbapenem-resistantEnterobacteriaceae (CRE). ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
44. Folan SA, Tverdek FP, Tarrand JJ, Shelburne SA, Raad I, Mulanovich VE, Marx KR, Aitken SL. Empiric Linezolid Treatment is Associated With Adverse Short-Term Outcomes in Patients With Linezolid-Resistant Staphylococcus epidermidis Bloodstream Infections. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
45. El Haddad H, Michael M, Hachem R, A-M C, Jiang Y, Yousif A, Raad S, Jordan M, Raad I. The Role of Procalcitonin in Guiding Antimicrobial Therapy Duration in Cancer Patients with Sepsis or Bloodstream Infections. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
46. Shah P, Hachem R, A-M C, Hussain A, Al Hamal Z, Yousif A, Jordan M, Micheal M, Raad I. Changing Epidemiology of Central Line Associated Blood Stream Infections (CLABSI) in Cancer Patients: Onset after Insertion. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
47. A-M C, Chaftari P, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Elickalputhenpura B, Tarrand J, Raad I. Improvement in the Diagnosis of Patients With Central Line Related Bloodstream Infections by Proper Blood Culture Drawing and Labeling in an Emergency Center. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
48. Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Antimicrobial Efficacy of Chlorhexidine-Minocycline/Rifampin (CHX-M/R) Coated Nephrostomy Catheter against Multi-drug Resistant Pathogens including Carbapenem-Resistant Enterobacteriaceae. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
49. Hachem R, Reitzel R, Rolston K, Raad I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) against 511 Gram-Negative Clinical Isolates obtained from cancer patients. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
50. Reitzel R, Rosenblatt J, Hachem R, Raad I. Efficacy of antimicrobial Gendine gloves in a broad-spectrum rapid-kill assessment of multidrug-resistant organisms including CRE pathogens. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
51. Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Development and Efficacy of Chlorhexidine (CHX)-Minocycline/Rifampin (MR) Impregnated Penile Implants Against Resistance Pathogenes. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
52. Comer J, Brasel T, Tigabu B, Reitzel R, Rosenblatt J, Raad I. Antiviral Activity of Gendine Gloves against Ebola Virus for Reducing Transmission in Ebola Treatment Settings. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
53. Zakhour R, Alawami H, Hachem R, Jiang Y, Michael M, Chaftari AM, Raad I. Current Epidemiology, Management and Outcome of Catheter-related Bloodstream Infections in a pediatric population : How is it different from adult population?. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
54. Jamal M, Hachem R, Rosenblatt J, Mcarthur M, Felix E, Jiang Y, Tailor R, Raad I. Development of Antimicrobial Gendine Coated Central Catheters: In Vivo Biocompatibility and In Vitro Efficacy. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
55. Torres HA, Roach L, Mahale P, Granwehr B, Blechacz B, Miller E, Borchardt R, Shukla B, Ericsson C, Raad I. Transdisciplinary approach to managing hepatitis C virus infection in patients at a tertiary care cancer center. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
56. Raad I, Chaftari AM, Zakhour R, Yousif A, Jiang Y, Jordan M, Al Hamal Z, Viola GM, Fisch M, Hachem R. Successful Salvage of vascular access in Central Line Associated Bloodstream Infections (CLABSI) Using Catheter Lock Consisting of Minocycline, EDTA and 25% Ethanol (M-EDTA-ETOH). ID Week 2015, San Diego CA, 2015. e-Pub 2015.
57. A-M C, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwwehr B, Gagel A, Jiang Y, Al Shuaibi M, Raad I. Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients. ID Week 2014, Philadelphia, Pennsylvania, 2014. e-Pub 2014.
58. Raad I, Mullane KM, Selleslag D, Thompson G, Neofytos D, Shoham S, Lee M, Maher R, Zeiher B, Marty FM. A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections. ID Week 2014, Philadelphia, Pennsylvania, 2014. e-Pub 2014.
59. Hachem R, Chaftari A, Yousif A, Al Hamal Z, Garoge K, Jordan M, Deshmukh P, Alshuaibi M, Rosenblatt J, Hamerschlak N, Sherif A, Kanj S, Raad I. A Novel Lock Solution For Salvaging Central Venous Catheter (CVC) In The Setting Of A Central Line Associated Bloodstream Infection (CLABSI). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C, 2014. e-Pub 2014.
60. Rosenblatt J, Reitzel RA, Jamal M, C Hirsch-Ginsberg F, Al Shuaibi M, Chaftari A, Hachem R, Raad I. Optimized Glyceryl Trinitrate (GTN)-Citrate-Ethanol Non-antibiotic, Antimicrobial Catheter Lock Solution for Prevention Of Central Line Associated Bloodstream Infections (CLABSIs). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C, 2014. e-Pub 2014.
61. Garoge K, Jamal MA, Rosenblatt J, Chaftari A, Hachem R, Raad I. Development Of Antimicrobial Coated Cannula For Continuous Subcutaneous Insulin Infusion (CSII) For Extended Durations. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C, 2014. e-Pub 2014.
62. Jordan M, Al Hamal Z, Yousif A, Deshmukh P, Garoge K, Jiang Y, Hachem R, Chaftari A, Raad I. How Often Is Central Line-Associated Blood Stream Infection (CLABSI) Identified As Catheter-Related Blood Stream Infection (CRBSI) In Cancer Patients? Challenging The New Guidelines. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C, 2014. e-Pub 2014.
63. Viola GM, Raad II, Baumann DP, Rolston KV, Crosby MA. Breast tissue expander-related infections. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C, 2014. e-Pub 2014.
64. Rosenblatt J, Hachem R, Reitzel R, Viola GM, Raad I. Synergistic, meltable antimicrobial wrap for reducing tissue expander infections in patients with breast reconstruction. ID Week: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Francisco, California, 2013. e-Pub 2013.
65. Hachem R, A-M C, El Zakhem A, Viola GM, Granwehr B, Gagel A, Jiang Y, Alshuaibi M, Raad I. Efficacy and safety of telavancin in the treatment of Gram-positive bloodstream infections in cancer patients. ID Week: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Francisco, California, 2013. e-Pub 2013.
66. A-M C, Alshuaibi M, Jamal M, Reitzel R, El Zakhem A, Jiang Y, Hachem R, Raad I. Role of procalcitonin in cancer patients with infections. ID Week: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Francisco, California, 2013. e-Pub 2013.
67. Nobuyoshi M, El Zakhem A, Williams P, Cantu S, Tarrand JJ, Raad I, Chemaly R, Adachi J. Improving the outcomes of cancer patients with multidrug-resistant gram negative rods bloodstream infections. ID Week: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Francisco, California, 2013. e-Pub 2013.
68. El Zakhem A, A-M C, Hachem R, Jiang J, Raad I. Use of antimicrobial central venous catheters for exchange over guidewire in Staphylococcus aureus central line associated bloodstream infection. ID Week: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Francisco, California, 2013. e-Pub 2013.
69. Jamal JA, A-M C, Dvorak T, Zakhem E, Rosenblatt J, Jiang Y, Hachem RY, Raad II. Prevention of transmission of multi-drug resistant organisms during catheter exchange using antimicrobial catheters. 53th Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado, 2013. e-Pub 2013.
70. Reitzel R, Rosenblatt J, Yiang Y, Hachem RY, Raad II. Hand hygiene beyond borders. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado, 2013. e-Pub 2013.
71. Mori N, DuPont H, Jiang ZD, El Zakhem A, Williams P, Van Tassel A, Cantu S, Good C, Dvorak T, Reitzel R, Tarrand JJ, Raad I, Chemaly R, Adachi JA. Increasing rates of multi-drug resistant organism bloodstream infections in a comprehensive cancer center: rifaximin as a novel alternative for antimicrobial prophylaxis. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Diego, California, 2012. e-Pub 2012.
72. Shomali W, Hachem R, Chaftari AM, Bahu R, Jiang Y, Reitzel R, El Helou G, Raad I. The role of procalcitonin and pro-adrenomedullin in differentiating organisms causing staphylococcal bacteremia. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Diego, California, 2012. e-Pub 2012.
73. El Zakhem A, Chaftari AM, Hachem R, Bahu R, El Helou G, Alshuaibi M, Raad I. Staphylococcus aureus (SA) central line associated bloodstream infections (CLABSI) in cancer patients: removal of the catheter and duration of therapy. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Diego, California, 2012. e-Pub 2012.
74. Hachem R, El Helou G, El Zakhem A, Shomali W, Jiang Y, Chaftari AM, Raad I. Caspofungin and voriconazole as primary and salvage therapy for patients with invasive aspergillosis in hematologic malignavcy. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. San Diego, California, 2012. e-Pub 2012.
75. Rosenblatt J, Hachem RY, Reitzel R, Chaftari A, Raad I. Pathogenesis and prevention of ventilator-associated pneumonia (VAP): an in vitro model using antimicrobial–coated endotracheal tube (ETT). 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California, 2012. e-Pub 2012.
76. Rosenblatt J, Hachem RY, Dvorak T, Reitzel R, Chaftari A, Alshuaibi M, Raad I. Glyceryl trinitrate (GTN) is useful as a novel non-antibiotic catheter lock for the prevention of intraluminal catheter biofilm colonization. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California, 2012. e-Pub 2012.
77. Reitzel R, Rosenblatt J, Hachem RY, Raad I. Novel water based method of impregnating exam gloves with gendine antiseptic. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California, 2012. e-Pub 2012.
78. Mohamed JA, Hachem RY, Chaftari A, Jiang J, Raad I. Efficacy of a novel gendine coated peripherally inserted central venous catheters (PICC) against multidrug-resistant pathogens. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California, 2012. e-Pub 2012.
79. Mohamed JA, Chaftari A, Hachem RY, Alshuaibi M, Raad I. Augmenting antibiotic-coated catheters (CVC) activity against bacterial biofilm adherence by impregnating the CVC with verapamil. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California, 2012. e-Pub 2012.
80. Shomali W, Bahu R, Jiang Y, Hanania A, Raad S, Hachem R, Chaftari AM, Raad I. Can procalcitonin (PCT) distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients (NNCP)?. 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
81. Mohamed J, Chaftari AM, Reitzel R, Jiang Y, Dvorak T, Hachem R, Raad I. Extended antimicrobial activity and prolonged durability of combination chlorhexidine (CHX) and minocycline/rifampin (M/R) coated vascular central venous catheters (CVC). 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
82. Hachem R, Debiane L, Shomali W, Bahu R, Al Wohoush I, Jiang Y, Hanania A, Raad S, Chaftari AM, Raad I. Comparing biomarkers procalcitonin (PCT) and pro-adrenomedullin (proADM) as a predictor of response to antibiotics in critically ill cancer patients with bacteremia and sepsis. 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
83. Hachem R, Mohamed J, Reitzel R, Jiang Y, Dvorak T, Chaftari AM, Raad I. Comparison of three antimicrobial coated peripherally inserted central venous catheters (PICCs): What is on the horizon?. 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
84. El Helou G, Hachem R, Chaftari AM, Tarrand J, Jiang Y, Raad I. El Helou G, Hachem R, Chaftari AM, Tarrand J, Jiang Y, Raad I. Rapidly growing mycobacteria (RGM) bacteremia in immunocompromised patients, clinical experience of 74 patients at MD Anderson Cancer Center. 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
85. Bahu R, Shomali, El Zakhem A, Ahrar K, Chaftari AM, Jiang Y, Hachem R, Raad I. Nephrostomy tube related infection (NTRI): epidemiology, risk factors, and infection rate in cancer patients. 49th Annual Meeting of the Infectious Diseases Society of America. October 20-23, 2011, Boston, Massachusetts, 2011. e-Pub 2011.
86. Mohamed JA, Reitzel R, Chaftari AM, Hachem R, Raad II. Activity of antimicrobial-coated endotracheal tubes (ETT) in preventing the biofilm colonization of resistant bacteria in a biofilm model with neutralizing broth. 48th Annual Meeting of the Infectious Diseases Society of America. Vancouver, Canada, 2010. e-Pub 2010.
87. Al Wohoush I, Cairo J, Debiane L, Chaftari AM, Hachem R, Raad II. Catheter related bacteremia (CRB) caused by Streptococcus viridans (SV) in cancer patients. 48th Annual Meeting of the Infectious Diseases Society of America. Vancouver, Canada, 2010. e-Pub 2010.
88. Debiane L, Hachem R, Al Wohoush I, Jiang Y, Chaftari AM, Raad II. Pro-adrenomedullin is predictive of response to antibiotics in critically ill cancer patients with bacteremia and sepsis. 48th Annual Meeting of the Infectious Diseases Society of America. Vancouver, Canada, 2010. e-Pub 2010.
89. Al Akhrass F, Haydoura S, Mohamed JA, Tarrand J, Kontoyiannis D, Hachem R, Chaftari AM, Raad II. Catheter-related and disseminated nocardia bacteremia: An emerging infection in cancer patients. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
90. Raad II, Dvorak T, Reitzel R, Jiang Y, Hachem R. Dowanol as bioenhancer of chlorhexidine to achieve a rapid kill against MRSA. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
91. Raad II, Al Akhrass F, Al Wohoush I, Reitzel R, Hachem R. Rhodococcus bacteremia is mostly catheter related and associated with biofilm formation. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
92. Al Wohoush I, Hachem R, Debiane L, Jabbour J, Jiang Y, Al Akhrass F, Chaftari AM, Raad II. Procalcitonin (PCT) is predictive of bloodstream infections (BSI) and metastatic disease but not localized bacterial infection (LBI) in non-neutropenic cancer patients (NNCP). 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
93. Raad II, Reitzel R, Dvorak T, Jiang Y, Chaftari A, Hachem R. Comparing chelator-based catheter lock solutions (CLS) in eradicating organisms in biofilm on catheter surfaces. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
94. Raad II, Mohamed J, Reitzel R, Jiang Y, Chaftari AM, Hachem R. The extended broad-spectrum activity of second generation minocycline and rifampin-coated catheters (M/R CVC) against bacteria and fungi. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
95. Al Akhrass F, Al Wohoush I, Reitzel R, Chaftari AM, Hachem R, Raad II. Rhodococcus bacteremia is mostly catheter-related and associated with biofilm formation. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, 2010. e-Pub 2010.
96. Ramos ER, Hachem R, Kassis C, Jiang Y, Raad I. Outcome Analysis of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP) Receiving Salvage Antifungal Therapy: The Role of Novel Azoles. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
97. Best L, Singh N, Ben-Ami R, Albert N, Raad II, Lewis RE, Kontoyiannis DP. In vitro interactions of Tacrolimus with Posaconazole of Aspofungin against Zygomycetes. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
98. Hachem R, Mihu C, Kassis C, A-M C, Kontoyiannis DP, Raad I. Does the Combination of Lipid Formulation of Amphotericin B (L-AmB) and Echinocandins (ECH) Improve the Outcome of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP)?. )? 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
99. Leventakos K, Re L, Chamilos G, Tamboli P, Raad II, Kontoyiannis D. Trends in epidemiology and sites of involvement by invasive fungal infections in patients with hematological malignancies: a 20-year autopsy study. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
100. Vigil KJ, Adachi JA, Ajami N, Johnston B, Z-D J, Tarrand J, Raad II, Johnson JR, Dupont HL. Clinical characteristics and virulence factors of Escherichia coli infections in cancer patients. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
101. Chemaly RF, Sikka MK, Rathod DB, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Raad I, Trenholme G. Outcome of Serratia marcescens bacteremia due to contaminated pre-filled heparin and saline flushes in 3 states. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
102. Campo M, Hachem R, Jiang Y, Chemaly RF, Carrilo-Marquez R, Hulton K, Raad I. Does Panton Valentine Leukocidin (PVL) Exotoxin influence the Outcome of Cancer Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infection?. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
103. Rathod DB, Vigil K, Adachi J, Shah J, Raad I. Clostridium difficile infection ion cancer patients. A case-control study. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
104. Al Wohoush I, Cairo J, Rivera J, Hachem R, Raad I. Is Molecular Genotyping Necessary for The Diagnosis of True Bacteremia Among Patients With Coagulase Negative Staphylococci (CoNS) from Blood Cultures?. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
105. Cairo J, Rangaraj G, A-M C, Granwehr B, Raad I. Is A Single Quantitative Blood Culture (QBC) Collected Through The Central Venous Catheter (CVC) Diagnostic of Catheter-Related Bloodstream Infections (CRBSIs)?. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
106. Al Akhrass F, Haydoura S, Melgarejo N, Tarrand J, Hachem R, Raad I. Clinical Characteristics and Outcome of Catheter-Related and Disseminated Nocardemia in Cancer Patients (pts). 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
107. Cairo J, Rangaraj G, Hachem R, Granwehr B, Raad I. Predictors of Catheter Related gram negative bacteremia (CR-GNB) in Cancer Patients. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
108. Shah JN, Hachem RY, Rathod DB, Adachi JA, Mulanovich VE, Raad II, Chemaly RF. Outcome of MRSA bacteremia (BSI) in cancer patients treated with vancomycin. 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, 2009. e-Pub 2009.
109. Raad I, Ramos E, Hachem R, Jiang Y, Torres H, Al-Akhrass F, Kontoyiannis D, Safdar A. Are White Blood Cell Transfusions (WBCT) Useful in the Salvage Treatment of Invasive Aspergillosis (IA) in Neutropenic Hematologic Malignancy Patients (HMP)?. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 2009. e-Pub 2009.
110. Chaftari A, Hachem R, Kassis C, El Issa H, Kassar R, Jiang Y, Raad I. Novel Approach Using Antimicrobial Catheters for Catheter Exchange in Patients with Catheter-Related Bacteremia (CRB): A Matched Controlled Study. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 2009. e-Pub 2009.
111. Hachem R, Ramos E, Kassis C, Jiang Y, Kontoyiannis D, Raad I. Comparing the Outcome of Invasive Aspergillosis (IA) Caused by Aspergillus terreus to A. fumigatus in Hematologic Malignancies Patients (HMP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 2009. e-Pub 2009.
112. Raad I, Hachem R, Dvorak T, Reitzel R. Evaluating the Efficacy of Anti-Infective Endotracheal Tubes (ETT) in Preventing Biofilm Colonization (BC) of Multi-resistant Bacteria (MDRB) Associated with Ventilator-Associated Pneumonia (VAP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 2009. e-Pub 2009.
113. Raad I, Hachem R, Ramos E, Kassis C, Jiang Y, Afif C, Torres H, Kontoyiannis D. Posaconazole (Posa) and Echinocandins (Ech) Combination: A Promising Salvage Therapy of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, 2009. e-Pub 2009.
114. A-M C, Hachem R, Mulanovich V, r C, Adachi J, Kassar C, Ramos E, Jiang Y, Raad I. Efficacy and Safety of Daptomycin in the Treatment of Gram Positive. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
115. Reitzel R, Dvorak T, Chaiban G, Jiang Y, Hachem R, Raad I. Comparing the Efficacy of Novel Anti-Infective Urinary Catheters: The Role of Gendine-Impregnated Catheters in Preventing the Adherence of Multidrug-Resistanc Organisms. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
116. Ghide S, Jiang Y, HachemR, Chaftari AM, Tarrand J, Raad I. Catheter-Related Corynebacterium Bacteremia: Should the Catheter Be Removed and Vancomycin Administered?. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
117. Rangaraj G, Granwehr B, Hachem R, Jiang Y, Raad I. Fluroquinolone Prophylaxis and the Risk of Breakthrough Bacteremia Caused by Multidrug Resistant Organisms in Cancer Patients. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
118. Kassis C, Rangaraj G, Jiang Y, Kassar R, Hachem R, Raad I. Role of Time to Positivity and Quantitative Blood Culture In Differentiating Coagulase Negative Staphylococcal Bacteremia from Contamination in Cancer Patients. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
119. Hachem R, Rivera J, Jiang Y, Reitzel R, Han Y, Raad I. The Diagnostic Utility of Quantittaive PCR and Galactomannan for the Diagnosis of Invasive Aspergillosis in Cancer Patients Receiving Anti-Mold Therapy. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
120. Kassar R, Hachem R, Jiang Y, Tarrand J, Raad I. Management of Catheter-Related Bacillus Bacteremia: The Need for Catheter Removal. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
121. Kassar R, Hachem R, Ghannam D, Jiang Y, Raad I. Should the Catheter Be Removed in Patients with True Coagulase Negative Staphylococcal Bacteremia?. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
122. Rivera J, Kassar R, Kassis C, Dvorak T, Gohar, Hachem R, Raad I. When Does Molecular Genotyping and Phenotyping of Coagulase Negative Staphylococci Isolated from Blood Culture Correlate with Clinical/CDC Criteria for True Bacteremia. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
123. Campo M, Hachem R, Jiang Y, Chemaly R, Carrilo-Marquez, Hulton K, Raad I. The Impact of Panton Valentine Leukocidin (PVL) Exotoxin on the Outcome of Cancer Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infection. Proceedings of the 48th ICAAC/IDSA, Washington, DC, 2008. e-Pub 2008.
124. Hachem R, Chemaly R, Jiang Y, Reitzel R, Dvorak T, Raad I. Anti-adherence Activity and Antimicrobial Durability of Anti-infective-Coated Catheters Against Multidrug-Resistant (MDR) Bacteria. Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2007, Chicago, IL, 2007. e-Pub 2007.
125. Safdar A, Ma J, Walsh TJ, Wingard JR, Chandrasekar PH, Kontoyiannis DP, Champlin RE, Raad II. Nephrotoxicity Associated with Amphotericin B (AmB) Lipid Complex (ABLC) versus Liposomal Amphotericin B (L-AmB). Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2007, Chicago, IL, 2007. e-Pub 2007.
126. Safdar A, Rodriguez GH, Shpall EJ, Walsh TJ, Kontoyiannis DP, Champlin RE, Kantarjian HM, Rolston KV, Raad II. High-Dose Caspofungin (HD-CAP) in Cancer Patients with Invasive Fungal Infections (IFIs). Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2007, Chicago, IL, 2007. e-Pub 2007.
127. Hachem R, Kontoyiannis DP, Chemaly R, Jiang Y, Reitzel R, Raad H. Galactomannan Enzyme Immunoassay (GM-EIA): Low Sensitivity for Aspergillus fumigatus Infection in Cancer Patients (pts). Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2007. e-Pub 2007.
128. Raad I, Hachem R, Jiang Y, Kantarjian H, Champlin R, Kontoyiannis D. Combination Salvage Therapy of Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM): Which Caspofungin-Containing Regimen?. Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2007, Chicago, IL, 2007. e-Pub 2007.
129. Langston AA, Graham DR, Graybill JR, Perfect JR, Pedicone LD, Raad II. Posaconazole treatment for invasive fungal infections in patients with underlying renal impairment. Abstracts of the European Association of Hospital Pharmacists. March 22-24, 2006, Geneva, Switzerland, 2006. e-Pub 2006.
130. Youssef S, Hachem R, Chemaly R, Adachi J, Jacobson K, Jiang Y, Rolston K, Safdar A, Kontoyiannis D, Raad I. Vitamin B6 was not effective for the prevention of hematologic toxicities of linezolid (LNZ) in cancer patients (pts). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
131. Raad I, Hanna H, Boktour M, Torres H, Afif C, Kontoyiannis D, Hachem R. Posaconazole (POS) compared to high dose lipid formulations of amphotericin B (HD-LPAMB) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
132. Hachem R, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Raad I. Activity of rifampin against MRSA embedded in biofilm: the risk of resistance if used alone and benefit of synergy if used in combination. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
133. Reitzel R, Shukrallah B, Hanna H, Dvorak T, Hachem R, Raad I. Gloves impregnated with antiseptic dyes are highly effective in the prevention of adherence of nosocomial resistant bacteria. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
134. Kontoyiannis DP, Chamilos, G, Lewis RE, Raad II, Han X. Increased bone marrow iron stores are an independent risk factor for invasive aspergillosis in severely Immunocompromised cancer patients: A case-control observational study. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
135. Chamilos G, Lionakis MS, Lewis RE, Raad II, Kontoyiannis DP. Epidemiology and outcome of zygomycosis in a tertiary care cancer center (1989-2006): A retrospective study of 95 episodes. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
136. Keutgen X, Ghannam D, Hackett B, Shukrallah B, Jiang Y, Chemaly R, Hanna H, Hachem R, Raad I. Differential quantitative blood cultures (QBC) for the diagnosis of catheter-related bloodstream infection: what is the cutoff ratio?. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
137. Shukrallah B, Hanna H, Ghannam D, Chatzinikolaou I, Hachem R, Raad I. Clinical response (CR) within 24 hours following catheter removal is useful in diagnosing catheter-related bloodstream infection (CRBSI). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
138. Hachem RY, Boktour MR, Hanna HA, Kontoyiannis DP, Keutgen X, Shukrallah B, Hanna E, Raad II. Sinus surgery (SS) improves the outcome of invasive Aspergillus sinusitis in neutropenic patients with hematologic malignancy (HM). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
139. Shukrallah B, Ghannam D, Hackett B, Keutgen X, Jiang Y, Hachem R, Chemaly R, Kontoyiannis D, Hanna H, Raad I. The utility of >100 CFU from the central venous catheter (CVC) in establishing the diagnosis of catheter-related bloodstream infection (CRBSI). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
140. Ghanem G, Graviss L, Chemaly R, Hanna H, Dvorak T, Hulten K, Hachem R, Raad I. The role of molecular methods in the prevention of nosocomial methicillin resistant Staphylococcus aureus (MRSA) clusters in cancer patients. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
141. Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly R, Raad I. Comparative analysis of vancomycin resistant Enterococcus (VRE) faecalis vs VRE faeciumin cancer patients. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15, 2006, Toronto, Ontario, Canada, 2006. e-Pub 2006.
142. Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Posaconazole (POS) compared to amphotericin B lipid formulations (AmB/LPD) in combination with caspofungin (CASP) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). Proceedings of the 2nd Advances Against Apsergillosis. February 22-25, 2006, Athens, Greece, 2006. e-Pub 2006.
143. Raad II. Posaconazole (POS) compared to amphotericin B lipid formulations (AmB/LPD) in combination with itraconazole (IT) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). Proceedings of the 2nd Advances Against Apsergillosis, February 22-25, 2006, Athens, Greece, 2006. e-Pub 2006.
144. Ghannam DE, Rodriguez GH, Adachi J, Chemaly R, Rolston KV, Raad II, Safdar A. Efficacy of inhaled (Ih) aminoclycosides (aG) and colistin (CL) in cancer patients with ventilator-associated pneumonia (VAP) during 2000-2005. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
145. Raad I, Hanna H, Boktour M, Torres H, Kontoyiannis D, Hachem R. The combination of caspofungin (C) and voriconazole (V) as primary and salvage therapy of invasive aspergillosis (IA) in hematologic malignancy patients (HMP). Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006, San Francisco, California, 2006. e-Pub 2006.
146. Aguilera EA, Torres HA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Raad II, Chemaly RF. Influenza infetion in adult patients with leukemia: the impct of neuraminidase inhibitors. [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
147. Aisenberg G, Jacobson K, Chemaly R, Rolston K, Raad I, Safdar A. Mycobacterium tuberculosis (Mtb) infection: clinical spectrum of active disease in cancer patients (2001–2005). [abstract]. Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
148. Ansari SR, Weiss LT, Hachem RY, Hanna HA, Safdar A, Boktour M, Rolston KV, Raad II. Role of prior antibiotic use in emergence of multidrug-resistant (MDR) Stenotrophomonas maltophilia in cancer patients. [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
149. Ghanem GA, Boktour MR, Warneke C, Bahna BN, Kassis K, Chemaly RF, Hachem RY, Raad II. Catheter-related Staphylococcus aureus bacteremia (CRSAB) in cancer patients: high complication rate associated with type of malignancy. [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
150. Hachem RY, Boktour M, Hanna HA, Torres H, Afif C, Kontoyiannis D, Raad II. Amphotericin B lipid complex (ABLC) vs. liposomal amphotericin B (L-AMB) monotherapy of invaisve aspergillosis (IA) in patients with hematological malignancy (HM). [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
151. Hachem RY, Chemaly RF, Ahmar C, Boktour M, Abou Rjaili G, Weiss LT, Bodey GP, Raad II. Does colistin have a role in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa (MDR-PSA) in cancer patients? [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
152. Kumashi P, Safdar A, Chemaly R, Chamilos G, Raad II, Kontoyiannis DP. Fungal osteoarticular infections (FOAI) in cancer patients (pts): a 10-year retrospective study. [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
153. Aboufaycal H, Adachi J, Hachem R, Weiss LT, Kontoyiannis DP, Safdar A, Chemaly R, Rolston K, Raad I. Risk factors and outcome of infection with multidrug-resistant (MDR) Escherichia coli in patients with cancer. [abstract] . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2005. e-Pub 2005.
154. Hachem R, Boktour M, Daugherty T, Pham-Williams T, Warneke C, Chemaly R, Raad I. The utility of galactomannan enzyme immunoassay (GM-EIA) and (1-3) B-D-glucan (BG) in the diagnosis of invasive fungal infections in cancer patients. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, 2005. e-Pub 2005.
155. Raad II, Hanna HA, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution and rapid eradication of organisms embedded in biofilm. [abstract]. Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
156. Hanna H, Kontoyiannis D, Buddineni J, Boktour M, Antoniadou A, Hachem R, Raad I. The changing epidemiology of candidemia in hematologic malignancy (HM): Candida glabrata and Candida krusei are the leading causes of fungemia. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
157. Hachem RY, Hanna HA, Dvorak T, Kontoyiannis DP, Raad II. Antifungal activity of amphotericin B lipid complex (ABLC) with EDTA against Candida embedded in biofilm. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
158. Hachem RY, Hanna HA, Dvorak T, Chemaly RF, Raad II. Activity of daptomycin and tigecycline against clinical isolates causing catheter-related methicillin-resistant Staphylococcus aureus (cR-MRSA) embedded in biofilm. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
159. Hachem RY, Bahna BH, Hanna HA, Raad II. EDTA as an adjunct antifungal agent for the treatment of invasive pulmonary aspergillosis (IPA) in a murine model. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
160. Bahna BN, Hanna HA, Dvorak T, Chaiban G, Chemaly RF, Hachem RY, Raad II. Gendine coated orthopedic metal devices (OMDs) for the prevention of bacterial infection. [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
161. Bahna BN, Hanna HA, Chemaly RF, Hachem RY, Raad II. Sources and outcomes of bloodstream infections (BSI) in cancer patients (pts): the role of quantitative blood cultures (QBC) and the central venous catheter (CVC). [abstract]. . Proceedings of the 45th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, 2005. e-Pub 2005.
162. Safdar A, Rodriguez G, Rolston K, Kantarjian H, Champlin R, Raad I, Kontoyiannis D. Efficacy of high-dose caspofungin in 22 cancer patients with invasive fungal infections. [abstract]. . Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, Denmark, 2005. e-Pub 2005.
163. Aisenberg G, Tarrand J, Rolston K, Kontoyiannis D, Raad I, Safdar A. Stenotrophomonas maltophilia: changing spectrum of bacterial pneumonia in cancer patients with low-suspicion of S. maltophilia infection [abstract]. . Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, Denmark, 2005. e-Pub 2005.
164. Chamilos G, Bodey GP, Luna M, Lewis RE, Rolston KV, Chemaly R, Safdar A, Raad I. Trends in incidence of invasive fungal infections at a tertiary cancer centre over a 14-year period: an autopsy study [abstract]. . Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, Denmark, 2005. e-Pub 2005.
165. Yusuf SW, Ali S, Tong A, Swafford J, Durand JB, Kontoyiannis DP, Rolston KV, Raad II, Safdar A. Clinical spectrum of endocarditis in patients with cancer: a case-control evaluation of culture-positive (CPE) and culture-negative (CNE) disease, 1994-2004. [abstract]. Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, Denmark, 2005. e-Pub 2005.
166. Aisenberg G, Tarrand J, Rolston K, Kontoyiannis D, Raad I, Safdar A. Stenotrophomonas maltophilia: changing spectrum of bacterial pneumonia in cancer patients with low-suspicion of S. maltophilia infection. 15th European Congress of Clinical Microbiology and Infectious Diseases April 2-5, 2005, Copenhagen, Denmark, 2005. e-Pub 2005.
167. Chamilos G, Bodey GP, Luna M, Lewis RE, Rolston KV, Chemaly R, Safdar A, Raad I. Trends in incidence of invasive fungal infections at a tertiary cancer centre over a 14-year period: an autopsy study. 15th European Congress of Clinical Microbiology and Infectious Diseases April 2-5, 2005, Copenhagen, Denmark, 2005. e-Pub 2005.
168. Safdar A, Rodriguez G, Rolston KV, Kantarjian H, Bodey G, Champlin R, Walsh TJ, Raad I, Kontoyiannis D. Efficacy of high-dose (100mg daily) caspofungin (HD-CASP) combination antifungal therapy in cancer patients with invasive fungal infections (IFIs): case-control observational analysis during 2002–2004. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans. Louisiana, 2005. e-Pub 2005.
169. Chemaly RF, Torres HA, Rohatgi N, Kontoyiannis DP, Safdar A, Kantarjian H, Daugherty T, Sepulveda C, Hachem R, Raad II. Human herpesvirus-6 (HHV-6) viremia is associated with donor granulocyte transfusions (gtx) in heavily immunosuppressed patients (pts) with leukemia. [abstract]. . Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans. Louisiana, 2005. e-Pub 2005.
170. Sader HS, Rolston K, Raad I, Desphande LM, Toleman M, Jones RN. Dissemination of blaVIM among clonally unrelated clinical strains isolated in a USA Medical Center. [abstract]. . Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans. Louisiana, 2005. e-Pub 2005.
171. Aisenberg G, Rolston K, Kontoyiannis D, Raad I, Safdar A. Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: matched case-control analysis in 44 individuals with low-risk of infection (1998–2004). [abstract]. . Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2005. e-Pub 2005.
172. Raad I, Boktour M, Hanna H, Kontoyiannis D, Hachem R. Posaconazole (POS) Compared to Amphotericin B Lipid Formulations (AmB/LPD) alone or in Combination with Itraconazole (IT) as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM) [Abstract No. 678]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:175, 2004. e-Pub 2004.
173. Graybill JR, Raad I, Negron R, Corcoran G, Pedicone L. Posaconazole (POS) Long-Term Safety in Patients with Invasive Fungal Infections (IFIs). [Abstract No. M1025]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
174. Raad I, Graviss L, Chemaly R, Hanna H, Hachem R, Hulten K, Kaplan S. The Perils of Molecular Typing: Does a Clonal Cluster of Nosocomial MRSA Always Imply Nosocomial Transmission? [Abstract No. K-70]. Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
175. Torres HA, Younes A, Aguilera EA, Kontoyiannis DP, Luna MA, Tarrand JJ, Nogueras GM, Raad II. Cytomegalovirus infection in patients (Pts) with lymphoma [Abstract No. 638]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:166, 2004. e-Pub 2004.
176. Chemaly RF, Perego C, Dvorak T, Toguchi A, Hulten K, Raad II. Outbreak of a community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) skin infection among healthcare workers (HCWs) [Abstract K96]. Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
177. Boktour MR, Hanna HA, Bahna BN, Tarrand JJ, Raad II. The central venous catheter (CVC) as a major source of Stenotrophomonas maltophilia bacteremia in cancer patients [Abstract No. 164]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:61, 2004. e-Pub 2004.
178. Perfect JR, Graham DR, Corcoran G, Pedicone L, Raad I. Posaconazole (POS) safety and efficacy in elderly patients with invasive fungal infections (IFIs) [Abstract No. 630]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:165, 2004. e-Pub 2004.
179. Ohmagari N, Kontoyiannis DP, Chemaly RF, Hachem R, Raad II. Invasive aspergillosis (IA) among cancer patients (pts) with solid tumor: a 10-year experience at a tertiary cancer hospital [Abstract No. 675]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:175, 2004. e-Pub 2004.
180. Kontoyiannis DP, Lionakis MS, Lewis RE, Walsh TJ, Raad II. Zygomycosis (Z) in the Era of Voriconazole (VRC) in a Cancer Center: a Matched Case-Controlled Observational Study of 27 Recent Patients (pts) [Abstract No. M-665]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
181. Kontoyiannis DP, Boktour M, Hanna H, Hachem RY, Raad II. Does Itraconazole (ITRA) Added to Amphotericin B or its Lipid Formulation (AMB/LPD) Improve Outcome of Primary Treatment of Invasive Aspergillosis (IA)? [Abstract No. M-1034]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
182. Raad I, Chapman S, Bradsher R, Morrison V, Goldman M, Graybill J, Perfect JR, Patterson T, Walsh T, Corcoran G, Pappas P. Posaconazole (POS) Salvage Therapy for Invasive Fungal Infections (IFI) [Abstract M669]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
183. Healy M, Walton D, Reece K, Bittner T, Manry J, Raad I, Kontoyiannis D. Identification and Molecular Typing of Clinical Fusarium Isolates by Two DNA Sequencing Methods and Automated rep-PCR [Abstract D465]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
184. Torres HA, Storey R, Chemaly RF, Aguilera E, Luna M, Rolston KVI, Raad II. Pneumocystis jiroveci pneumonia in a cancer center: influence of HIV status to presentation and outcome [Abstract No. 687]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:177, 2004. e-Pub 2004.
185. Raad II, Hachem RY, Boktour MR, Chemaly RF, Daugherty TC, Hanna H. Real time PCR (RT-PCR) and galactomannan (GM) for the diagnosis of invasive aspergillosis (IA) in cancer patients [Abstract No. 620]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:164, 2004. e-Pub 2004.
186. Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Posaconazole (POS) Compared to Amphotericin B Lipid Formulations (AmB/LPD) in Combination with Caspofungin (CASP) as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM) [Abstract No. M-1035]. . Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
187. Healy M, Reece K, Walton D, Lising M, Bittner T, Frye S, Schrock R, Raad II, Kontoyiannis DP. Identification and Strain Discrimination of Clinical Candida Bloodstream Isolates Using the DiversiLab System and DNA Sequencing [Abstract D464]. Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2004. e-Pub 2004.
188. Hachem RY, Boktour MR, Hanna HA, Tarrand JJ, Kontoyiannis DP, Chemaly RF, Pham-Williams T, Daugherty TC, Raad II. Serum galactomannan (GM): which assay (ELISA or LATEX) is useful in diagnosing invasive aspergillosis (IA)? [Abstract No. 617]. Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:162, 2004. e-Pub 2004.
189. Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Caspofungin (CASPO) Amphotericin B Lipid Formulations (AmB/LPD) or the Combination as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM) [Abstract No. 678]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, Massachusetts:175, 2004. e-Pub 2004.
190. Hachem RY, Hogan HH, Coyle EA, Neuhauser MM, Garey K, Raad II. The safety and toxicity of linezolid in bone marrow transplant patients [Abstract No. 1694]. . Proceedings of the 45th Annual Meeting of the American Society of Hematology. San Diego, California, 2003. e-Pub 2003.
191. Darouiche R, Mansouri D, Raad I. In vivo analysis of antimicrobial-impregnated catheters on antimicrobial resistance [Abstract No. 556]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
192. Boktour M, Hanna H, Kontoyiannis D, Hachem R, Girgawy E, Bodey G, Raad I. Multiple species candidemia (MSC) in cancer patients: risk factors and response to antifungal therapy [Abstract No. 391]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
193. Torres HA, Raad II, Reddy BT, Kontoyiannis DP. Pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans [Abstract No. 352]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
194. Ohmagari N, Hanna H, Graviss, Hackett B, Perego C, Gonzalez V, Dvorak T, Hogan H, Rolston K, Raad I. Risk factors for multi-drug resistant Pseudomonas aeruginosa (MDR-Psa) among hospitalized cancer patients [Abstract No. 384]. Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
195. Hogan H, Chemaly RF, Coyle EA, Kamana M, Kontoyiannis DP, Safdar A, Bodey GP, Raad II. Early combination antiviral therapy for cytomegalovirus (CMV) infection in patients with hematological malignancies [Abstract No. 364]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
196. Hanna H, Chatzinikolaou I, Alakech B, Hachem R, Lewis R, Kontoyiannis D, Tarrand J, Raad I. Differential positive quantitative blood cultures (DPQBC) and the diagnosis of catheter-related bloodstream infections (CRBSI) [Abstract No. 334]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
197. Hachem R, Rice L, Hanna H, Dvorak T, Rolston K, Arbuckle R, Chaiban G, Raad I. Molecular patterns of decreased vancomycin-resistant Enterococcus faecium (VREF) susceptibility to linezolid (LZD) associated with clinical use [Abstract No. 216]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
198. Hachem R, Graviss, Arbuckle R, Hanna H, Dvorak T, Hackett, Gonzalez V, Osting C, Tarrand J, Raad I. The impact of vancomycin-resistant enterococcal (VRE) stool surveillance (SS) in patients with hematologic malignancy (HM) on controlling outbreak bacteremias [Abstract No. 379]. . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
199. Girgawy E, Hanna H, Graviss L, Chaiban G, Hachem R, Dvorak T, Chemaly R, Raad I. Chest tube (CT) related multidrug-resistant Staphylococcus aureus (MRSA) empyema: could the CT be coated with antiseptics? [Abstract No. 389] . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, California, 2003. e-Pub 2003.
200. Hanna HA, Chaiban G, Raad II. A rapid method of impregnating endotracheal tubes (ETT) and urinary catheters (UC) with a novel antiseptic agent [Abstract No. K-131]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
201. Ezzet F, Wexler D, Courtney R, Martinho M, Cellary A, Huber C, Hachem R, Kontoyiannis D, Topelt K, Corcoran G, Cornely OA, Raad I, Ullmann AJ. Comparative bioavailability of oral posaconazole (POS) in different dosage regimens: a population pharmacokinetic analysis [Abstract No. A-1565]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
202. Chatzinikolaou I, Hanna H, Darouiche R, Rolston KVI, Raad I. A prospective study evaluating the clinical value of quantitative blood cultures (QBC) collected through central venous catheters (CVC) [Abstract No. D-1698]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
203. Ullmann AJ, Cornely GA, Burchardt A, Huber C, Hachem R, Kontoyiannis DP, Tolpelt K, Lahey J, Ezzet F, Courtney R, Corcoran G, Raad I. Safety and efficacy of posaconazole (POS) in a pharmacokinetic study in patients with febrile neutropenia (FN) or refractory invasive fungal infection (rIFI) [Abstract No. M-1257]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
204. Ezzet F, Wexler D, Courtney R, Martinho M, Cellary A, Huber C, Hachem R, Kontoyiannis D, Topelt K, Corcoran G, Cornely OA, Raad I, Ullmann AJ. Comparative bioavailability of oral posaconazole (POS) in different dosage regimens: a population pharmacokinetic analysis [Abstract No. A-1565]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
205. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Raad II. Donor granulocyte transfusions in cancer patients with hematogenous candidiasis – impact on fungemia outcome [Abstract No. M-969]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
206. Rolston KVI Raad II. In vitro activity of quinolones against viridans streptococci isolated from cancer patients [Abstract No. E-155]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
207. Rolston KVI, Kontoyiannis DP, Raad II. In vitro activity of new quinolones against non-fermentative gram-negative bacilli (NFGNB) isolated from cancer patients [Abstract No.E-148]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
208. Raad II, Hachem RY, Hanna H, Rolston KVI. Myalgias/arthralgias (MA) occurring in patients receiving quinupristin/dalfopristin (QD) may be related to biliary dysfunction [Abstract No. A-522]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
209. Raad II, Hanna HA, Chaiban G, Dvorak T, Boktour, M, Jabbour N, Murray BE. The presence of the esp gene bioprosthetic colonization, and DNA restriction pattern of vancomycin-resistant Enterococcus faecium (VREF) causing catheter-related bacteremia (CRB) [Abstract K-1109]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
210. Raad II, Hanna HA, Chatzinikolaou I, Hachem RY, Tarrand J. Is clinical response (CR) following catheter removal useful in diagnosing catheter-related bloodstream infection (CRBSI)? [Abstract No. K-137] . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
211. Raad II, Chaiban G, Hanna HA, Dvorak T, Lewis R, Darouiche R, Hachem R. Activity of antibiotics against resistant gram-positive organisms (RGPO) embedded in biofilm [Abstract No. C1-1118]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
212. Wiederhold NP, Coyle EA, Chi J, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bloodstream infection [Abstract No. A-1163]. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
213. Mattiuzzi G, Kantarjian H, Alvarado G, Kontoyiannis D, Pierce S, Cortes J, Giles F, Leitz G, Raad I, Verstovsek S, Estey E. Intravenous itraconazole (ITRA) vs. caspofungin (CASPO) prophylaxis (P) in patients (pts) with acute myleogenous leukemia (AML) and myelodysplastic syndrome (MDS) undergoing induction chemotherapy (IC) [Abstract No. M-984]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
214. Lionakis MS, Lewis RE, Torres HA, Rolston KV, Raad II. In vitro susceptibility of Aspergillus clinical isolates to amphotericin B (AMB), itraconazole (ITZ) and voriconazole (VRC) by E-test and the effect of prior antifungal exposure [Abstract No. M-1248]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
215. Greenberg RN, Anstead G, Herbrecht R, Langston A, Marr K, Mullane K, Raad I, Schiller G, Schuster M, Van Burik J, Wingard JR, Hare R, Corcoran G. Posaconazole (POS) experience in the treatment of zygomycosis [Abstract No. M-1757]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
216. Hanna HA, Chaiban G, Smith D, Citron R, Raad I. Durability of gendine impregnated silicone and polyurethane central venous catheters [Abstract No. K-146]. . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2003. e-Pub 2003.
217. Rolston KVI, Kontoyiannis DP, Raad II, LeBlanc BJ, Streeter HL, Ho DH. Susceptibility surveillance among gram-negative bacilli at a comprehensive cancer center. [Abstract No. 2362) . 103rd General Meeting American Society of Microbiology. Washington, D.C, 2003. e-Pub 2003.
218. Hachem R, Kontoyiannis D, Boktour M, Afif C, Cooksley C, Chatzinikolaou I, Raad I. Invasive aspergillosis (IA) with Aspergillus terreus (AT) and Aspergillus fumigatus (AF): a comparative analysis of risk factors and outcome in cancer patients [Abstract No. 338]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
219. Chagua M, Hachem R, Raad I, Kontoyiannis D. Trichosporonosis in a tertiary care cancer center: risk factors, spectrum and determinants of outcome [Abstract No. 367]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
220. Andrade R, Hanna H, Alvarez-Cruz A, Tarrand J, Raad I. Catheter-related septic thrombosis caused by Candida: Clinical characteristics and management [Abstract No. 406]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
221. Yardegarynia D, Rolston KV, Tarrand J, Raad II. Current spectrum of bacterial infection in patients with hematologic malignancies (HM) and solid tumors (ST) [Abstract No. 139]. Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
222. Sohn S, Yokoe DS, O’Rourke S, Hanna H, Raad I, Perl TM, Jaffe D, Sepkowitz KA. Healthcare-associated bloodstream infection (BSI) in allogeneic hematopoietic stem cell transplant (HSCT) recipients at 4 major transplant centers [Abstract No. 391]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
223. Kontoyiannis DP, Hanna H, Hachem R, Boktour M, Girgawy E, Mardani M, Bodey G, Raad I. Risk factors of poor outcome of fusariosis in a tertiary care cancer center [Abstract No. 366]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
224. Hanna H, Boktour M, Bodey G, Girgawy E, Kontoyiannis D, Hachem R, Raad I. Candida parapsilosis fungemia (CPF) responds better to antifungal therapy than fungemia due to Candida albicans (CAF) in immunocompromised cancer patients [Abstract No. 349]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
225. Chatzinikolaou I, Hanna H, Finkel K, Boktour M, Foringer J, Ho T, Raad I. The role of polyurethane hemodialysis central venous catheters impregnated with minocycline and rifampin (H-CVC-MR) in preventing catheter-related infections: a prospective randomized study [Abstract No. 387]. . Proceedings of the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Illinois, 2002. e-Pub 2002.
226. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T. In vitro and ex vivo activity of minocycline and EDTA (M-EDTA) against microorganisms embedded in biofilm on catheters [Abstract No. K-75]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
227. Raad I, Hanna HA, Arbuckle RB, Chaiban G, Dvorak, Hachem RY. Susceptibility patterns of vancomycin-resistant enterococci (VRE) to quinupristin/dalfopristin (QD) and linezolid (LZD) before and after clinical use [Abstract No. E-1134]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
228. Raad I, Hanna H, Jabbour N, Boktour M, Dvorak T, Chaiban G, Hachem R. Molecular and clinical epidemiology of vancomycin-resistant enterococcal catheter-related bacteremia (VRE-CRI) [Abstract No. K-76]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
229. Raad II. Catheter-related bloodstream infections [Abstract No. 1162]. Meet-the-Experts. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
230. Pham AS, Tarrand JJ, May GS, Lee MS, Raad II. Diagnosis of invasive mold infection by a quantitative real-time PCR [Abstract No. 903]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
231. Maertens J, Raad I, Petrikkos G, Selleslag D, Petrsen F, Sable C, Kartsonis N, Ngai A, Taylor A, Patterson T, Denning D, Walsh T. Update of multicenter noncomparative study of caspofungin (CAS) in adults with Invasive aspergillosis (IA) refractory ® or intolerant (I) to other antifungal agents: analysis of 90 patients [Abstract No. M-868]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
232. Lewis RE, Torres HA, May GS, Raad II, Thornby J, Rolston KV, Upadhyaya D, Bodey GP, Kontoyiannis DP. In vitro Susceptibility and Tolerance of Aspergillus Species (Spp) in a Tertiary Care Cancer Center. Correlation with Invasive Aspergillosis (IA) and its Outcome [Abstract No. M-1491]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
233. Kontoyiannis DP, Lewis RE, May GS, Albert ND, Raad I. Sequential Exposure of A. fumigatus to Itraconazole (ITRA) and Caspofungin (CAS): Evidence of Enhanced In Vitro Activity of this Combination [Abstract No. M-851]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
234. Kontoyiannis DP, Hachem R, Lewis RE, Rivero G, Kantarjian H, Raad I. Efficacy and toxicity of the caspofungin/liposomal amphotericin B (CAS/LipoAMB) combination in documented or possible invasive aspergillosis (IA) in patients (Pts) with hematologic malignancies [Abstract No. M-1820]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
235. Hanna H, Graviss L, Chaiban G, Dvorak T, Arbuckle R, Estey E, Munsell M, Hachem R, Champlin R, Raad I. Susceptibility patterns of Staphylococcus organisms in leukemia and bone marrow transplant (BMT) services after the use of minocycline/rifampin-impregnated central venous catheters (MR-CVCs) in a cancer hospital [Abstract No. K-75]. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
236. Hanna H, Dvorak T, Raad I. Lactoferrin (LF) and EDTA synergistic activity: an alternative antibiotic catheter lock solution [Abstract No. E-1650]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
237. Hachem R, Wright KC, Zermeno A, Bodey GP, Raad II. Safety and long-term durability of the silver iontophoretic catheter in an animal model [Abstract No. B-271]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
238. Antoniadou A, Torres H, Lewis RE, Raad II, Thornby J, Tarrand JJ, Rolston K, Han X, Bodey G, Kontoyiannis DP. In vitro Susceptibility of Bloodstream Candidiasis (BC) in Cancer Patients: Correlation with outcome of antifungal therapy [Abstract No. M-1499]. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California, 2002. e-Pub 2002.
239. Hanna H, Benjamin R, Chatzinikolaou I, Richardson D, Marts K, Mansfield P, Raad I. The Role of Long-term Silicone Central Venous Catheters Impregnated with Rifampin and Minocycline (S-CVC-RM) in Preventing Catheter-related Infections: A Prospective Randomized Study . Proceedings of The 38th Conference of The American Society of Clinical Oncology (ASCO). Orlando, Florida, 2002. e-Pub 2002.
240. Chatzinikolaou I, Zipf T, Roberts M, Sherertz R, Hanna H, Raad I. Minocycline and EDTA (M-EDTA) as a flush solution for implantable ports (IP) used in pediatric cancer patients [Abstract No. 52676]. Proceedings of the 12th Annual Meeting of the Society for Healthcare Epidemiology of America. Salt Lake City, Utah, 2002. e-Pub 2002.
241. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B (AmB), itraconazole (ITR), and voriconazole (VOR) in an in vitro model of Candida catheter-related bloodstream infection (CRBSI) [Abstract J-108]. . Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
242. Lewis RE, Lo H, Raad II, Kontoyiannis DP. Lack of catheter colonization by the cph1/cph1 efg1/efg1 double null mutant, a C. Albicans strain that is defective in filamentous growth [Abstract No. J-109]. . Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
243. Nabulsi N, Hanna HA, Raad II. Devices impregnated with novel antiseptic agents: broad-spectrum activity and prolonged antimicrobial durability [Abstract K-1459]. Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
244. Raad II, Hanna HA, McFadyen S, Marts K, Richardson D, Hachem RY. Nontunneled subclavian central venous catheters (NTSC) vs. tunneled central venous catheters (CVCs) and ports in cancer patients [Abstract K-2049]. Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
245. Hanna HA, McFadyen S, Marts K, Richardson D, Raad II. Prospective evaluation of 1.67 million catheter-days of peripherally inserted central catheters (PICCs) in cancer patients: long durability and low infection rate [Abstract K-2045]. . Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
246. Kontoyiannis DP, Reddy BT, Bodey GP, Luna M, Tarrand J, Lewis RE, Rolston K, Whimbey E, Jacobson K, Nguyen M, Raad II. Pulmonary candidiasis (PC) in cancer patients (pts): an autopsy study [Abstract No. J-677]. . Proceedings of the 41st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, 2001. e-Pub 2001.
247. Bodey GP, Boktour M, May S, Duvic M, Girgawy E, Kontoyiannis D, Hachem R, Raad I. Cutaneous manifestation of Fusarium infections. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2001. e-Pub 2001.
248. Raad II, Escalante C, Hachem R, Hanna H, Afif C, Boktour M, Whimbey E, Kontoyiannis D, Jacobson K, Bodey G, Rolston K. Comparison between imipenem/cilastatin (I) and cefepime (C) as initial therapy for febrile neutropenic cancer patients (PTS) requiring hospitalization. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2001. e-Pub 2001.
249. Raad II, Graham D, Hanna H, Chatzinikolaou I, Cooper A. Treatment of catheter-related staphylococcal bacteremia (CRBS) with quinupristin/dalfopristin (Q/D) vs. vancomycin or nafcillin: a prospective, randomized study. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2001. e-Pub 2001.
250. Afif C, Hanna HA, Alakech B, Boktour M, Tarrand J, Hachem R, Raad II. Central venous catheter-related Gram-negative bacteremia (CRGNB): significance of catheter removal in preventing relapse. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2001. e-Pub 2001.
251. Hicks K, Hachem RY, Huen A, Raad II. Myelosuppression and serotonin syndrome associated with linezolid and selective serotonin re-uptake inhibitors (SSRIS). . Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California, 2001. e-Pub 2001.
252. Hanna H, Raad I, Danawi H, Boktour M, Girgawy E, Mardani M. Candidemia in patients with intravascular catheter: when should the catheter be removed? [Abstract No. 266] . Proceedings of the 11th Annual Meeting of the Society for Healthcare Epidemiology. Toronto, Ontario:96, 2001. e-Pub 2001.
253. Shaikh ZHA, Osting C, Hanna H, Raad I. Effectiveness of multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant Enterococci at a tertiary-care center [Abstract No. 165]. Proceedings of the 11th Annual Meeting of the Society for Healthcare Epidemiology. Toronto, Ontario:75, 2001. e-Pub 2001.
254. Raad I, Tarrand J, Hanna H, Boktour M, Mardani M, Hachem R, Rolston K. Epidemiology, molecular mycology and environmental sources of Fusarium infection in cancer patients [Abstract No. 209]. . Proceedings of the 11th Annual Meeting of the Society for Healthcare Epidemiology. Toronto, Ontario:84, 2001. e-Pub 2001.
255. Hanna H, Alakech B, Chatzinikolaou I, Darouiche R, Rolston K, Whimbey E, Hachem R, Raad I. Predictors of catheter-related bloodstream Infections (CRBSI) in cancer patients with bacteremia or fungemia. Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA:112, 2000. e-Pub 2000.
256. Hachem RY, Raad II, Afif CM, Negroni R, Graybill J, Hadley S, Kantarjian H, Adams S, Mukwaya G. An open, non-comparative multicenter to evaluate efficacy and safety of posaconazole (SCH 56592) in the treatment of invasive fungal infections (IFI) refractory (R) to or intolerant (I) to standard therapy (ST). . Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:372, 2000. e-Pub 2000.
257. Ghosh S, Koller CA, Kantarjian HM, Keating MJ, Raad II, Rolston KV, Kontoyiannis DP, Jacobson KL, Whimbey EE. Therapy of RSV pneumonia in myelosuppressed adults with leukemia: combination aerosolized ribavirin and immunotherapy. Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA:146, 2000. e-Pub 2000.
258. Ghosh S, Champlin RE, Ueno NT, Rolston KV, Raad II, Jacobson KL, Kontoyiannis DP, Whimbey EE. RSV infections in autologous blood and marrow transplant (BMT) recipients with breast cancer: combination therapy with aerosolized ribavirin and immunotherapy. Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA:146, 2000. e-Pub 2000.
259. Darouiche RO, Fowler V, Adal KA, Kielhofner M, Reller, LB, Mansouri D, Raad II. Antimicrobial activity of prosthetic heart valve sewing cuffs coated with Minocycline and rifampin (M/R). . Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA:109, 2000. e-Pub 2000.
260. Raad II, Hanna HA, Alakech B, Chatzinikolaou I, Rolston KVI, Whimbey E, Tarrand JJ. Diagnosis of catheter-related bloodstream (CRBSI): Differential time to positivity (DTP) for short-term and long-term central venous catheters (CVC) [Abstract No. 1426]. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:421, 2000. e-Pub 2000.
261. Raad II, Hanna HA, Sumoza LD, Albitar M. Using peripheral blood and polymerase chain reaction (PCR) in the diagnosis of invasive pulmonary aspergillosis (IPA) in cancer patients. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:380, 2000. e-Pub 2000.
262. Raad I, Huaringa A, Sumoza D, Hanna HA, Rolston KV, Kontoyiannis D, Hachem RY, Albitar M. Diagnosis of Invasive pulmonary aspergillosis (IPA) using polymerase chain reaction (PCR) based detection of Aspergillus in bronchoalveolar lavage (BAL). Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America. New Orleans, LA:47, 2000. e-Pub 2000.
263. Maertens J, Raad I, Sable CA, Ngai A, Berman R, Patterson TE, Denning D, Walsh T. Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory ( R) or intolerant (I) to amphotericin B(AMB), AMB lipid formulations (Lipid AMB), or azoles [Abstract No. 1103]. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:370, 2000. e-Pub 2000.
264. La Rosa AM, Champlin RE, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Whimbey E. Therapy of invasive adenovirus infections in adult blood and marrow transplant (BMT) recipients. Is intravenous (iv) ribavirin efficacious? [Abstract No. 73]. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:256, 2000. e-Pub 2000.
265. Kontoyiannis DP, Vaziri I, Hanna H, Thornby J, Boktour M, Hachem R, Bodey GP, Raad II. Risk factors for Candida tropicalis fungemia in patients with cancer [Abstract #232]. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:360, 2000. e-Pub 2000.
266. Kontoyiannis DP, Peitsch WK, Reddy BT, Han XY, Raad II, Bodey GP, Rolston KVI. Cryptococcus in the 90’s in a tertiary care cancer center [Abstract #1694]. . Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada:389, 2000. e-Pub 2000.
267. Hanna H Raad I. Protection and risk factors associated with long-term catheter infections in cancer patients. . Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA, 2000. e-Pub 2000.
268. Raad I, Hackett B, Hanna H, Graviss L, Botz G. Use of antibiotic impregnated catheters associated with significant decrease in nosocomial bloodstream infections in critically ill cancer patients. Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA, 2000. e-Pub 2000.
269. Raad I, Hanna H, Hachem R, Darouiche R. Diagnosis of catheter-related bloodstream infection: is it necessary to culture the subcutaneous segment? . Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA, 2000. e-Pub 2000.
270. Raad I, Osting C, Hanna H, Hachem R, Umphrey J, Tarrand J, Kantarjian H. Masking of neutropenic patients upon transport from patient rooms is associated with decrease in nosocomial aspergillosis during construction. Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA, 2000. e-Pub 2000.
271. Chatzinikolaou I, Rolston K, Raad I. Central venous catheter-related Rhodococcus spp. bacteremia in cancer patients. Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA, 2000. e-Pub 2000.
272. Bleyer A, Mason L, Raad I, Sherertz R. A randomized double-blind trial comparing minocycline/EDTA vs heparin as flush solution for hemodialysis catheters. Proceedings of the 10th Annual Meeting of the Society for Healthcare Epidemiology. Atlanta, GA:91, 2000. e-Pub 2000.
273. Hachem RY, Afif C, Cooksley C, Boktour M, Chatzinikolaou I, Khan A, Kontoyiannis D, Rolston KV, Raad II. Invasive aspergillosis (IA) In patients with leukemia and bone marrow transplant patients (pts): poor outcome despite aggressive therapy (Abstract No. 3815). Blood 96(11):36b, 2000. e-Pub 2000.

Book Chapters

1. Raad I, Malek A. Catheter and Device Related Infections. In: Oncologic Critical Care. Springer International Publishing, 2020.
2. Assaf, A, Wang EW, Raad I. Catheter-Related Infections. In: Critical Care Medicine, 5th Edition. Lippincott, Williams & Wilkins, Inc, 2017.
3. Chaftari, A-M, Raad I. Intravascular catheter-related infections. In: Clinical Infectious Diseases, Second Edition. 2nd. Cambridge University Press, 2015.
4. Al Hamal Z, Jordan M, Raad I. Infection of the salivary and lacrimal glands. In: Clinical Infectious Disease, Second Edition. Cambridge University Press, 68-74, 2015.
5. Lewis RE, Raad II. Treatment Protocols for Infections of Vascular Catheters. In: Biofilms Infection & Antimicro Therapy. Taylor & Francis Group, CRC Press, 409-426, 2015.
6. Yousif A, Mohamed J, Raad I. Biofilm-Based Central Line-Associated Bloodstream Infections. In: Biofil-Based Healthcare-Associated Infections. Springer International Publishingw, 2015.
7. Al Wohoush I, A-M C, Raad I. Catheter-Related Infections in Cancer Patients. In: Principles and Practice of Cancer and Transplant Infections. Springer Science, 2013.
8. Ghannam DE, Raad I. Intravascular Catheter-Related Infections. In: Clinical Infectious Disease. 3rd. Mosby, Inc, 2009.
9. Safdar A, Raad I. Management of Infections in Patients with Gynecologic Malignancy. In: Principles and Practice of Gynecologic Oncology, 5th Edition. Lippincott Williams & Wilkins/Wolters Kluwer, 2009.
10. Raad I, Hanna HA, Maki DG. Bacterial Infectious Disease Issues: Catheter-related Infections. In: Internal Medicine Care of Cancer Patients. People's Medical Publishing House, 2009.
11. Ghannam DE, Raad I. Catheter-Related Infections. In: Critical Care Medicine. Lippincott, Williams & Wilkins, Inc, 2009.
12. Youssef S, Raad I. Infections of the Salivary and Lacrimal Glands. In: Clinical Infectious Disease. 3rd. Mosby, Inc, 2009.
13. Raad I. Novel Technologies in the Prevention of Catheter Infections. In press. In: Vascular Access Devices. Jones and Bartlett, Inc, 2005.
14. Safdar A, Raad I. Nosocomial Infections and Antibiotic Therapy in Patients With Cancer. In: Acute Care of the Cancer Patient. Taylor and Francis, 829-847, 2005.
15. Raad II, Hanna HA. Catheter-associated Infection and Bacteremia. In: Hospital Medicine. 2nd. Lippincott, Williams & Wilkins, 703-710, 2005.
16. Lewis RE, Raad II. Treatment Protocols for Infections of Vascular Catheters. In: Biofilms Infection, and of Antimicrobial Therapy. CRC Press LLC, 405-421, 2005.
17. Chatzinikolaou I Raad I. Diagnosis of catheter-related infections. In: Reanimation en Onco-Hematologie. Elsevier SAS, 109-119, 2004.
18. Chatzinikolaou I, Raad I. Catheter-Related Infections. In: Infections in Cancer Patients. Marcel Dekker, Inc, 379-418, 2004.
19. Raad, I, Hanna, H. Nosocomial Infections Related to Use of Intravascular Devices Inserted for Long-Term Vascular Access. In: Hospital Epidemiology and Infection Control, 3rd Edition. Lippincott, Williams & Wilkins, 2004.
20. Hanna, HA, Raad I. Medical Implications of Biofilms. In: Intravascular-Catheter-Related Infections. Cambridge University Press, 2003.
21. Chatzinikolaou I, Raad I. Central Venous Catheter Related Infections: The Role of Antimicrobial Catheters. In: Immunology and Infectious Disease. Kluwer Academic Publishers, 187-215, 2003.
22. Samaha R, Raad I. Emergent and Serious Infections in Cancer Patients. In: Oncologic Emergencies. B.C. Decker, Inc, 145-160, 2002.
23. Hanna HA Raad I. Medical Implications of Biofilm on Intravascular Catheter-related Infections. In: Medical Implications of Biofilm. Cambridge University Press, 2002.
24. Afif C, Raad II. Intravascular catheter-related infections. In: Current Therapy of Infectious Disease. Mosby, Inc, 416-418, 2001.
25. Afif C Raad I. Evaluation and Management of Vascular Access Device Infections in Febrile Neutropenic Cancer Patients. In: Textbook of Febrile Neutropenia. Martin Dunitz Ltd, 189-200, 2001.
26. Raad I, Umphrey J. Catheter-Related Bloodstream Infections: Evaluation of CDC Guidelines. In: Saunders Infection Control Reference Service. W. B. Saunders, 281-284, 2001.
27. Hachem RY, Raad II. Infection of the salivary and lacrimal glands. In: Current Therapy of Infectious Disease. Mosby, Inc, 27-31, 2001.
28. Hanna H, Raad I. Prevention of catheter-related infections. In: Critical Care Infectious Diseases Textbook. Kluwer Academic Publishers, 587-596, 2001.
29. Gajewski JL Raad I. Vascular Access Catheters and Devices. In: Cancer Treatment. W. B. Saunders Co, 225-229, 2001.
30. Husni R, Raad I. Meningitis. In: Infections in Neurosurgery. American Association of Neurological Surgeons, 181-189, 2000.
31. Raad I Hanna H. Nosocomial infections related to use of intravascular devices inserted for long-term vascular access. In: Hospital Epidemiology and Infection Control. Lippincott, Williams & Wilkins, 165-172, 1999.
32. Rolston KVI, Raad I, Whimbey E, Bodey GP. The changing spectrum of bacterial infections in febrile neutropenic patients. In: Febrile Neutropenia. Springer-Verlag, 53, 1998.
33. Raad I, Umphrey J. Catheter-Related Bloodstream Infections: Evaluation of CDC Guidelines. In: Saunders Infection Control Reference Service. W. B. Saunders, 1998.
34. Buzaid AC, Raad I. Neutropenia and Fever. In: Decision Making in Medicine. Mosby-Year Book, Inc, 246-247, 1998.
35. Raad I, Alrahwan A. Catheter-related bacteremia. In: Pharmanual – Treatment of Severe Gram-positive Infections: The Role of Quinupristin/Dalfopristin. PharmaLibri Publishers, Inc, 3-20, 1998.
36. Darouiche RO, Raad II. Prevention of Infections Associated with Vascular Catheters. In: 1998 Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag, 327-338, 1998.
37. Raad I, Safdar H. Long-Term Central Venous Catheters. In: Catheter-Related Infections. Marcel Dekker, Inc, 1997.
38. Garcia R, Valdez L, Raad I. Catheter Infections and Thrombosis. In press. In: Vascular Access Devices. Jones and Bartlett, Inc, 1997.
39. Garcia R, Raad I. Infections of the Salivary and Lacrimal Glands. In: Current Therapy of Infectious Disease. Mosby-Year Book, Inc, 1996.
40. Raad I, Fraschini G. Intravascular Device Related Infections in Cancer Patients. In: Infectious Complications of Cancer. Kluwer Academic Publishers, 1995.

Letters to the Editor

1. Yadegarynia D, Tarrand J, Raad I, Rolston K. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 37: 1144-5, 2003.

Patents

1. Raad I, Hanna H, Nabulsi N. Novel Antiseptic Derivatives with Broad Spectrum Antimicrobial Activity for Impregnation of Surfaces. Patent Number: 7,713,472.
2. Raad I. Method for Imparting Antimicrobial Activity to A Medical Device. Patent Number: PCT/US2010/027768.
3. Raad I. Methods for Coating Medical Devices with Antiseptic Agents. Patent Number: PCT/US2006/60929.
4. Raad I, Rosenblatt J. Antimicrobial Solutions with Enhanced Stability. Patent Number: HK1260945.
5. Raad I, Rosenblatt J. Antimicrobial Solutions with Enhanced Stability. Patent Number: 6820921.
6. Raad I, Rosenblatt J. Antimicrobial Solutions with Enhanced Stability. Patent Number: 3370794.
7. Raad I, Rosenblatt J. Antimicrobial Compositions Comprising Glyceryl Nitrates. Patent Number: 6175140.
8. Raad I, Rosenblatt J. Antimicrobial Compositions Comprising Glyceryl Nitrates. Patent Number: 2882433.
9. Raad I, Rosenblatt J. Antimicrobial Compositions Comprising Glyceryl Nitrates. Patent Number: 2013299575.
10. Raad I, Rosenblatt J. Antimicrobial Catheters. Patent Number: 2986342.
11. Raad I, Rosenblatt J. Antimicrobial Catheters. Patent Number: 6594295.
12. Raad I, Rosenblatt J. Antimicrobial Catheters. Patent Number: 602014069188.9.
13. Raad I. Method for Imparting Antimicrobial Activity to a Medical Device. Patent Number: GB2480791.
14. Raad I. Methods for Coating Medical Devices with Antiseptic Agents. Patent Number: 1960013.
15. Raad I. Methods for Coating Medical Devices with Antiseptic Agents. Patent Number: 2,630,454.
16. Raad I. Antimicrobial Flush Solutions. Patent Number: 1644024.
17. Raad I. Antimicrobial Flush Solutions. Patent Number: 2,528,522.
18. Hanna H, Nabulsi N, Raad I. Novel Antiseptic Derivatives with Broad Spectrum Antimicrobial Activity for Impregnation of Surface. Patent Number: Serial No. PCT/US2002/00781.
19. Hanna H, Nabulsi N, Raad I. Novel Antiseptic Derivatives with Broad Spectrum Antimicrobial Activity for Impregnation of Surface. Patent Number: 1349455.
20. Raad I, Rosenblatt J. Antimicrobial Compositions and Uses Thereof. Patent Number: 17/360,966.
21. Raad I, Rosenblatt J, Dennis A, Selber J, Viola G. Antimicrobial Wraps for Medical Implants. Patent Number: 10,953,137.
22. Raad I, Rosenblatt J. Antimicrobial Compositions Comprising Glyceryl Nitrates. Patent Number: 9,913,820.
23. Raad I, Rosenblatt J. Antimicrobial Catheters. Patent Number: 16/924,096.
24. Raad I, Rosenblatt J. Antimicrobial Catheters. Patent Number: 10,744,232.
25. Raad I. Methods for Coating Medical Devices with Antiseptic Agents. Patent Number: 10,589,003.
26. Raad I. Methods for Coating Surfaces with Antimicrobial Agents. Patent Number: 10,589,003.
27. Dennis A, Raad I, Rosenblatt J, Selber J, Viola G. Antimicrobial Wraps for Medical Implants. Patent Number: 10,434,221.
28. Raad I, Rosenblatt J. ANTIMICROBIAL COMPOSITIONS AND USES THEREOF. Patent Number: 11,065,223.
29. Raad I, Bodey GP, Zermemo A. Antimicrobial Catheter. Patent Number: 5,409,647.
30. Antimicrobial Solutions. Patent Number: 9,565,857.
31. Raad I, Rosenblatt J, Dennis A, Selber J, Viola G. Antimicrobial Wraps for Medical Implants. Patent Number: 9,849,217.
32. Raad I, Rosenblatt J. Antimicrobial Compositions Comprising Glyceryl Nitrates. Patent Number: 9,457,002.
33. Raad I, Rosenblatt J. Antimicrobial Catheter Lock/Flush Solutions with Enhanced Stability. Patent Number: 10,086,114.
34. Raad I, Bodey GP, Zermeno A. Antimicrobial Catheter. Patent Number: 5,324,275.
35. Tcholakian RK, Raad I. A Multipurpose Antimicrobial Silastic Sheath System for the Prevention of Device-Related Infections. Patent Number: 5,820,607.
36. Raad I, Sherertz R. Antimicrobial medical devices. Patent Number: 5,362,754.
37. Raad I. Antimicrobial Flush Solutions. Patent Number: 7,601,731.
38. Raad I. Method for Imparting Antimicrobial Activity to a Medical Device. Patent Number: 8,426,044.
39. Raad I. Antimicrobial Flush Solutions. Patent Number: 9,078,441.
40. Raad I. Antimicrobial Flush Solutions. Patent Number: 8,709,342.
41. Raad I, Hanna H, Nabulsi N. Medical Devices with Broad Spectrum Antimicrobial Activity. Patent Number: 7,651,661.
42. Raad I, Sherertz R. Chelators in Combination with Biocides: Treatment of Microbially Induced Biofilm and Corrosion. Patent Number: 6,267,979.
43. Darouiche R, Raad I. Antimicrobial Impregnated Catheters and Other Medical Implants. Patent Number: 5,902,283.
44. Raad I, Sherertz R, Darouiche R. Non-Glycopeptide Antimicrobial Agents in Combination with an Anticoagulant Agent, and Their Uses in, for Example, the Preparation of Medical Devices. Patent Number: 5,688,516.
45. Darouiche R, Raad I. Antimicrobial Impregnated Catheters and Other Medical Implants and Method for Impregnating Catheters and Other Medical Implants with an Antimicrobial Agent. Patent Number: 5,624,704.
46. Raad I, Darouiche R. Antimicrobial Coated Medical Implants. Patent Number: 5,217,493.
47. Raad I, Sherertz R. M-EDTA Pharmaceutical Preparations and Uses Thereof. Patent Number: 5,362,754.
48. Raad I, Sherertz R, Hachem R. EDTA and Other Chelators With or Without Antifungal Antimicrobial Agents for the Prevention and Treatment of Fungal Infections. Patent Number: 6,165,484.